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1 ABSTRACT
1 Abstract
Intracellular calcium levels are tightly regulated and control many biological func-
tions through direct interactions with proteins or indirectly by modifying calcium-
binding proteins. In the glomerulus, the filtration unit of the kidney, podocytes form
a crucial part of the filtration barrier and podocyte injury is strongly associated
with loss of kidney function. Patient mutations in the podocyte calcium channel
TRPC6 demonstrated that both loss-of-function or gain-of-function mutations can
induce kidney disease indicating that a regulated calcium homeostasis is needed to
prevent podocyte damage.
The at hand thesis aimed to understand calcium dynamics in healthy and
injured podocytes in vivo. Previous studies in mice have demonstrated that activity
of the Angiotensin II (AngII) receptors, predominately AngII type 1 receptor
(AT1R), is associated with podocyte injury and increased intracellular calcium
levels. Using intravital microscopy of the kidney we can show that podocytes
maintain a low intracellular calcium level at baseline while stimulation with AngII
results in calcium transients in a minor fraction of podocytes and glomeruli. Next,
we caused podocyte injury by either inducing Adriamycin nephropathy or deleting
the slit diaphragm component podocin resulting in proteinuria and FSGS-lesions in
the kidney. Strikingly, AngII treatment of mice with preexisting glomerular disease
resulted in increased responsiveness to AngII with a significant higher percentage
of glomeruli and podocytes showing a calcium transient.
Furthermore, we wanted to investigate the role of ATP-mediated calcium signals
in different cell types of the nephron. Therefore, we generated mouse lines expressing
the calcium indicator GCaMP3 specifically in endothelial cells, proximal tubular
cells or podocytes. We can demonstrate that endothelial cells and proximal tubular
cells display a strong calcium response to ATP in vivo, while this is absent in
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podocytes at the same dose. This is in line with our ex vivo data obtained from
isolated glomeruli. Here, podocytes show a response to ATP only at higher doses.
In summary, our in vivo data challenge the current concepts of receptor mediated
calcium signaling in healthy podocytes while revealing a more pronounced role of
calcium signaling in podocyte’s pathophysiology.
2
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2 Zusammenfassung
Die intrazelluläre Kalziumkonzentration wird streng reguliert und kontrolliert
viele biologische Funktionen durch direkte Wechselwirkungen mit Proteinen oder
indirekt durch die Modifikation von Kalzium-bindenden Proteinen. Im Glomerulus,
der Filtrationseinheit der Niere, bilden Podozyten einen entscheidenden Teil der
Filtrationsbarriere und Podozytenverletzungen resultieren in einem Verlust der
Nierenfunktion. Patientenmutationen im Podozytenkalziumkanal TRPC6 zeigen,
dass sowohl eine "Gain-of-function" als auch eine "Loss-of-function" Mutation
des Kalziumkanals eine Nierenerkrankung auslösen kann. Dies weist darauf hin,
dass eine regulierte Kalziumhomöostase erforderlich ist, um eine Schädigung der
Podozyten zu verhindern.
Der Schwerpunkt dieser Arbeit lag auf der Untersuchung der Kalziumdynamik
in gesunden und kranken Podozyten in vivo. Frühere Studien an Mäusen haben
gezeigt, dass die Aktivität der Angiotensin-II (AngII) Rezeptoren, vorwiegend
des AngII-Typ-1-Rezeptors (AT1R), mit einer Podozytenverletzung und einer Er-
höhung des intrazellulären Kalziumspiegels verbunden ist. Mithilfe der intravitalen
Nierenmikroskopie können wir zeigen, dass Podozyten basal einen niedrigen in-
trazellulären Kalziumspiegel beibehalten, während die Stimulation mit AngII nur
zu Kalziumtransienten in einem geringen Teil von Podozyten und Glomeruli führt.
Als nächstes verursachten wir eine Schädigung der Podozyten, indem wir entweder
eine Adriamycin-Nephropathie induzierten oder die Schlitzmembrankomponente
Podocin deletierten. Bemerkenswerterweise führte die Stimulation mit AngII bei
Mäusen mit vorbestehender glomerulärer Erkrankung zu einer erhöhten Kalziu-
mantwort, wobei ein signifikant höherer Prozentsatz an Glomeruli und Podozyten
einen Kalziumtransienten aufwies.
Zudem wollten wir die Rolle von ATP-vermittelten Kalziumsignalen in ver-
schiedenen Zelltypen des Nephrons untersuchen. Hierzu haben wir verschiedene
3
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Mauslinien generiert, welche den Kalziumindikator GCaMP3 spezifisch in En-
dothelzellen, proximalen Tubuluszellen oder Podozyten exprimieren. Wir können in
vivo zeigen, dass Endothelzellen und proximale tubuläre Zellen eine starke Kalziu-
mantwort auf ATP zeigen, während diese in Podozyten bei gleicher Dosis ausbleibt.
Dies steht im Einklang mit unseren ex vivo Daten, welche mit isolierten Glomeruli
generiert wurden. Hier zeigen Podozyten nur bei hohen Dosen eine Reaktion auf
ATP.
Zusammenfassend stellen unsere in vivo Daten die gegenwärtigen Konzepte
der Rezeptor-vermittelten Kalziumsignalübertragung in gesunden Podozyten in
Frage, während sie eine bedeutendere Rolle der Kalziumsignalübertragung in der
Pathophysiologie von Podozyten aufdecken.
4
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3 Introduction
3.1 Podocyte biology & pathobiology
Kidneys generate approximately 180 liter of ultrafiltrate per day consisting of
electrolytes, low molecular weight waste and water. A complex reabsorbtion and
concentration mechanism of the tubular system results in a final urine volume of
about 1 liter per day [1]. The primary filtrate is generated in the glomerulus, the
filtration unit of the kidney. Blood enters the glomerulus via the afferent arteriole
and exits it via the efferent arteriole. In between, the blood is passing through
the capillary loops where filtration occurs. The primary filtrate is collected in the
Bowman’s space, from where it enters the proximal tubule. Filtration is achieved
by a highly developed filtration barrier, whose size and charge selectively retains
proteins and molecules of more than ∼ 70 kDa in the blood (Figure 1).
Podocyte 
(visceral 
epithelial cell) 
Capillary 
loop 
Urinary 
space 
Glomerular 
basement 
membrane 
VASCULAR 
POLE 
URINARY
POLE 
capsule 
Proximal
tubule 
 
Figure 1: Schematic representation of the glomerular filtration unit. The
blood enters the glomerulus via the afferent arteriole at the vascular pole and passes
through the capillary loops, where filtration occurs and exits via the efferent arteriole.
The generated primary urine is excreted into the Bowman’s space where it passed on
to the proximal tubule. (adapted from Leeuwis et al. 2010, [2])
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The filtration barrier is formed by a complex spatial arrangement of three layers:
a fenestrated endothelial cell layer, the glomerular basement membrane and the
podocyte slit diaphragm [3, 4] (Figure 2). Thereby podocytes play a critical role
in maintaining the function of the filtration barrier. Podocytes are terminally
differentiated epithelial cells, which sit on the glomerular basement membrane
(GBM) and wrap around the capillaries. Podocytes originate from mesenchymal
cells during kidney development. In the course of nephrogenesis podocytes lose
their mitotic activity and start to express distinctive proteins responsible for the
formation of specialized cell-cell contacts, termed slit diaphragm, and adapt a highly
sophisticated cell shape [3, 5, 6]. Each podocyte can be structurally subdivided
into a large cell body, primary processes and small finger like extensions called
foot processes. Foot processes of neighboring podocytes are interdigitating and are
connected by the slit diaphragm establishing a filtration slit with of ∼ 40 nm [7].
Fenestrated endothelium 
Podocyte 
foot process 
URINARY 
SPACE 
BLOOD 
Filtration 
Slit 
diaphragm 
Figure 2: Detailed schematic view of the filtration barrier. Composition of
the filtration barrier: fenestrated endothelial cells, the glomerular basement membrane
and the slit diaphragm in between podocyte foot processes. (adapted from Leeuwis
et al. 2010, [2])
The consequence of incorrect slit diaphragm formation for kidney diseases was
identified in children with mutations of nephrin, encoded by the NPHS1 gene. Mu-
6
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tation of NPHS1 results in congenital nephrotic syndrome of the Finnish type [8, 9].
Since then a number of slit diaphragm protein complex including Zonula Occludens-
1 (ZO-1), podocin, Neph1 and 2, CD2AP and many more have been identified as
crucial slit diaphragm components [10, 11, 12]. Nephrin is a transmembrane protein
with an extracellular domain and a short intracellular tail. The extracellular domain
interacts with Nephrin and Neph1 expressed on the cell membrane of neighboring
podocytes thereby spanning the filtration slit. Its intracellular domain allows
interaction with signaling proteins and can be phosphorylated at conserved tyrosine
and threonine residues [13, 14]. Thus important cellular functions and programs
including cell polarity, actin organization, cell survival and membrane trafficking
are tightly connected to the slit diaphragm and the maintenance of the filtration
barrier [13]. Since podocytes lose their ability to divide during nephrogenesis, any
podocytes lost due to disease or acute injury cannot be replaced. Podocyte injury
goes in hand with loss of their complex foot process structure resulting in the
so-called "foot process effacement". Thereby, foot processes apparently fuse and
flatten, completely abrogating the formation of a functional kidney filter. Finally,
podocytes can detach from the basement membrane, resulting in hypertrophy of
the remaining podocytes and ultimately in scarring of the glomeruli. Disruption of
the slit diaphragm results in loss of proteins into the urine, termed proteinuria [5].
Kidney diseases presenting with a large proteinuria (>4 g/day) lead to the clinical
picture of nephrotic syndrome, consisting of edema, proteinuria and hyperlipidemia.
Causes of podocyte injury can be classified into three main categories: congenital,
hereditary and acquired. Podocyte disease with congenital presentation are for
example the Finnish nephropathy [8, 9]. Lack of proteins essential for podocyte
architecture lead to an immediate phenotype even before birth. Hereditary causes
are commonly found as mutations in genes encoding for podocyte specific proteins
such as podocin, α-actinin-4 and TRPC6 [15, 16, 17, 18] with clinical disease
7
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onset during childhood or adolescence. Podocyte injury produced by acquired
factors can be separated into immune-mediated and non-immune causes. The
first comprises diseases involving dysregulation of the immune system, such as
membranous nephropathy and minimal change disease. Non-immune causes of
podocyte injury represent the most common cause of nephrotic syndrome often
caused by chronic hypertension, diabetes or infections [19, 20]. In most cases
podocyte injury ends in a common pathological glomerular phenotype called focal
segmental glomerulosclerosis (FSGS). Patients presenting with FSGS show sclerotic
glomerular lesions in the kidney but not all glomeruli and not all regions of a
glomerulus are affected. Therefore, the remaining functional glomeruli encounter
increased filtration resulting in increased cell stress and ultimately loss of nephron
function [21].
3.2 Calcium signaling
Calcium is a mediator of many different molecular processes in a cell. In general,
intracellular calcium levels are maintained at a low level of ∼100 nM while extra-
cellular calcium levels can be up to 20,000 fold higher [22]. Calcium can either
exert its effects by directly binding to a target protein or indirectly by binding to
calcium-sensing proteins, where it induces conformational changes which enable the
sensing protein to bind its target proteins to induce signaling. Thus, calcium is able
to influence many different cellular functions like cell motility, regulated cell death,
proliferation and metabolism [23]. The consequences of calcium on cytoskeletal
organization have been elegantly presented by the group of Roland Wedlich-Söldner.
They defined a mechanism of calcium-mediated actin reset (CaAR), in which stimu-
lation of Ca2+ induced actin rearrangement in many different mammalian cell types,
including podocytes [24]. Furthermore, dysregulation of intracellular calcium levels
have profound effects on cell viability. Many signaling pathways activate calcium
8
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release from intracellular stores like the endoplasmatic reticulum (ER) and/or
direct influx from the extracellular space to transmit their information. Therefore,
tight regulation of cytosolic calcium levels is required for cell homeostasis.
3.2.1 Calcium signaling in podocytes
In 2005 Winn and colleagues reported that a gain-of-function mutation of the tran-
sient potential receptor cation channel 6 (Trpc6) causes focal segmental glomerus-
losclerosis (FSGS) in patients [16, 17], a phenotype which could by recapitulated
in mice by overexpressing mutant Trpc6 channels [25]. On the other hand, loss-of-
function mutations found in humans have been associated with FSGS as well [26],
which further emphasizes the importance of maintenance of a calcium homeostasis.
The Trpc channel family comprises a large number of ion channels in different mam-
malian species. Trpc1 and Trpc3-6 have been shown to be expressed in podocytes
[27]. They form ion channels out of four subunits with each subunit containing six
transmembrane domains with the C- and N-terminus facing the cytoplasm. Trpc6
harbors four ankyrin repeats on his N-terminus responsible for protein-protein
interactions [28]. The Trpc6P112Q mutation resulting in overactivation is located
on the first ankyrin repeat [16, 29, 30]. Trpc6 is an unselective cation channel,
permeable for monovalent cations and calcium ions (Ca2+). Studies demonstrated
that it localizes in podocytes within the cell body and at the foot processes to
the slit diaphragm. There it interacts directly with CD2AP, nephrin and podocin
[17]. Opening of Trpc6 channels can be induced by different factors including
diacylglycerol (DAG), Ca2+ itself and agonists of phospholipase-C-(PLC)-linked
receptors [31, 30, 32]. DAG is a product of PLC activation which results in cleavage
of the membrane lipid phosphatidylinositol-4,5-biphosphate (PIP2) to diacylglyc-
erol (DAG) and inositol-1,4,5-triphosphate (IP3). DAG remains at the plasma
membrane due to its hydrophobic tail and can activate Trpc6 while IP3 can activate
9
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calcium channels on the ER resulting in release of Ca2+ into the cytoplasm. PLC
itself is activated by ligands binding to G-protein coupled receptors (GPCRs) on
the plasma membrane [32] (Figure 3).
L
PLC
IP3
DAG
Ca2+
Trpc6
stretch
Release of Ca2+
from ER
Podocin
GPCRs
1
2
3
Figure 3: Simplified overview of Trpc6 activation in podocytes. Activation
of Trpc6 can be mediated by different stimuli. Ligands can bind to G-protein coupled
receptors (GPCRs) on the plasma membrane triggering activation of phospholipase-C
(PLC) and subsequently production of Diacylglyerol (DAG) which directly activates
Trpc6 (1). Simultaneous generation of inositol-1,4,5-triphosphate (IP3) can induce
Ca2+ eﬄux from the endoplasmatic reticulum (ER) inducing activation of Trpc6 (2).
Finally, mechanical stretch on the plasma membrane which can be modulated by
podocin can activate Trpc6 (3).
Additional, studies indicate that Trpc6 is part of a mechanosensitive complex
including nephrin, podocin, CD2AP and α-actinin-4 [27]. In C. elegans the podocin
homologue Mec2 interacts with Trpc6 in a cholesterol dependent manner and thereby
changes Ca2+ conductivity (Figure 3) [33]. And in vitro studies have established
that mutant Trpc6N143S shows loss of Ca2+ channel activity upon osmotic stretch
[34]. Taken together there is evidence that Trpc6 activity is regulated by mechanical
strain on podocytes, but the published data is insufficient to draw a conclusion
whether this is a direct or indirect effect [35, 36]. Despite general effects of calcium
on various signaling pathways it has been shown that activation of Trpc6 directly
effects the elaborate actin cytoskeleton of podocytes and therefore plays a role in
disease [37]. Tian et al. (2010) demonstrated that activation of Trpc6 activated
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Rac1, a small GTPase, resulting in loss of stress fibers while activation of the
Trpc5 activated RhoA and thereby preserving cytoskeletal organization [38]. The
effects of Rac1 on podocyte morphology have been also presented in vivo [39].
Physiological factors such as Angiotensin II (AngII) and adenosine-triphosphate
(ATP) and have been linked to Trpc6 activation.
3.3 The renin-angiotensin-aldosterone system in the kidney
The renin-angiotensin-aldosterone system, short RAAS, is the main signaling path-
way regulating systemic blood pressure and salt balance. Renin is an aspartyl
protease which is primarly synthesized and secreted in the kidney from the juxta-
glomerular (JG) apparatus, situated at the branching point of the afferent arteriole
leading to the glomerular vascular bed [40]. Renin levels are regulated either
by signaling of baroreceptors located on endothelial cells and on JG cells or by
sodium chloride levels in the filtrate of distal tubules sensed by macula densa cells.
Drops in renal perfusion pressure as well as reduced sodium chloride levels increase
expression and secretion of renin. The hormone aldosterone is produced by the
adrenal gland plays and important role in electrolyte homeostasis [41]. The main
active compound of RAAS is angiotensin II (AngII). AngII is synthesized in two
steps: first renin cleaves a 10 amino acid long peptide from the N-terminus of
angiontensinogen (Agt) resulting in AngI. The main source of Agt are liver cells. In
a second step AngII is generated by removal of 2 amino acids from the C-terminus
of AngI by the angiotensin-converting-enzyme (ACE). ACE is a dicarboxydasepep-
tidase, which is expressed as a membrane bound form on the surface of endothelial
cells or is present as a soluble form in the plasma. The hormone AngII binds either
angiotensin II type 1 (AT1) or type 2 (AT2) membrane receptors. In humans a
single gene on chromosome 3 encodes for AT1 (Atrg1 ) while mice and rats harbor
two genes (Atrg1a and Atrg1b) on two chromosomes resulting in two subtypes
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of the AT1 receptor: AT1A and AT1B [42, 43]. Studies using overexpression and
knock-out mouse models indicate that AT1A has a predominant role in the kidney
mediating vasoconstriction and regulation of blood pressure [44, 45]. Still, both
receptor subtypes have been found to be expressed in podocytes [46].
3.3.1 AngII signaling as a mediator of podocyte injury
Blockade of AngII signaling in chronic kidney disease using ACE-inhibitors or AT1
receptor blockers (ARBs) such as Losartan is a mainstay of treatment in patients
suffering from diabetic and non-diabetic nephropathy. However, the mechanisms of
how RAAS inhibition prevents kidney disease progression are not fully understood.
In the kidney AngII regulates glomerular perfusion by increasing resistance
at the exit of the glomerular vascular bed. Thus local AngII physiologically
counteracts drops in renal perfusion pressure to keep the glomerular filtration
pressure constant. Upon RAAS overactivation the AngII levels are increased, which
results in swelling of the capillary loops due to increased filtration pressure as
AngII induces vasoconstriction of the efferent arteriole [1]. Furthermore, it has
been validated that overexpression of the AT1R in podocytes of rats is sufficient
to induce glomerulusclerosis [47]. Thus the effects of AngII can be separated into
hemodynamic and non-hemodynamic effects.
Prolonged activation of the AngII pathway occurs during hypertension or dia-
betic nephropathy resulting in glomerular injury [48, 49]. Glomerular hypertension
has been modeled in rats and mice by either feeding desoxycorticosterone acetate
(DOCA) or by reduction of kidney mass by 5/6 nephrectomy [50, 51, 52]. In both
models administration of ARBs or ACE inhibitors resulted in ameliorating effects
which are not solemnly accounted for by decreasing systemic blood pressure [53, 54].
Numerous in vitro and in vivo studies suggested that AngII can directly stimu-
late podocytes. Using cell culture and isolated glomeruli it has been presented that
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administration of AngII results in a robust increase of calcium levels of podocytes
[55, 56, 57, 27, 58]. AngII receptors belong to the group of G-protein coupled
receptors and their activation has been associated with elevated calcium levels
in podocytes via Trpc6 [16, 59]. Furthermore, experiments identified that AT1
activation relates to levels of nephrin expression and thereby influences slit di-
aphragm stability while administration of ACE or AT1 blockers restores nephrin
protein levels [60, 61, 62]. Furthermore, AngII signaling has been shown to induce
accumulation of reactive oxygen species (ROS) in mice [63, 64]. In the past years
AngII-mediated calcium signaling has been in the focus of podocyte research. Still
there is an on-going debate on whether the effects on calcium signaling are due to
direct binding of AngII to its receptor expressed on the podocyte cell membrane or
whether the induced mechanical stress activates calcium signaling in podocytes.
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3.4 Purinergic signaling and podocytes
Podocytes have been demonstrated to express adenosine-triphosphate (ATP) recep-
tors and upregulation of these receptors occurs during disease [65, 66]. Purinergic
signaling plays a role in mediating intracellular and extracellular signals. Release of
purinergic nucleotides such as ATP into the extracellular space is often associated
with a pathological cell state. Two families of receptors are activated by purinergic
nucleotides: P2X and P2Y. P2X receptors are cation channels activated by ATP,
while P2Y receptors belong to the group of G-protein coupled receptors (GPCRs)
and can be activated by different nucleotides such as adenosine-diphosphate (ADP),
uridine-diphosphate (UDP), uridine-triphosphate (UTP) and ATP. In context of
the kidney, activation of both receptors plays a role in regulating tubular function
and vasoconstriction [67, 68, 69]. In general these nucleotides have a short half-life
due to a fast degradation by ectonucleases present in almost all compartments of the
nephron including the glomerulus [70]. There is evidence that P2X7 and P2Y1 play
a role in kidney disease [65, 71, 72]. Data from hypertensive and diabetic nephropa-
thy models in rats suggest an upregulation of P2X7 in podocytes during disease [65]
while whole-body deletion of P2X7 ameliorates experimental glomerulonephritis
[72]. Experiments using podocyte cell culture identified a role of P2Y receptors in
mediating calcium signaling via Trpc6. Thereby it is proposed that ATP induces
calcium transients in a fashion similar to AngII by binding to its receptor, since
both receptor types belong to the family of GPCRs [66]. Using isolated glomeruli,
the P2Y1 receptor has been identified as the most abundantly expressed P2Y
receptor on podocytes [73]. However, podocyte cell culture data suggest that P2Y2
and P2Y6 play a predominant role in ATP mediated calcium increases [74]. The
controversy regarding receptor type and subtype might be based on the model
system used and differences in experimental set up [74, 35]. Additionally, it has
been shown that podocytes themselves are able to release ATP upon mechanical
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stretch which can then again activate P2X4 channels. Further, activation of P2X4
induces actin reorganization and thus might contribute to podocyte injury [35].
Besides podocytes themselves, endothelial cells, erythrocytes, mast cells as well
as sympathic and parasympathic nerve endings have been identified as sources of
extracellular ATP [67]. ATP also plays a role in mediating calcium transients in
the tubuloglomerular feedback (TGF) as studies revealed propagation of calcium
signal from the juxtaglomerular cells to endothelial cells and finally to podocytes
[75]. Finally, there is evidence for a role of in mediating a calcium wave from one
podocyte to the next upon acute podocyte laser-induced injury using intravital
microscopy, which could be slowed down by inhibition of purinergic receptors and
deletion of P2Y2 [75]. Taken together, purinergic signaling influences podocyte
biology, even though the detailed effects of the different receptors involved and the
downstream signaling molecules remain elusive.
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3.5 In vivo imaging of the kidney using multiphoton microscopy
3.5.1 Characteristics of multiphoton microscopy
Technical advances over the last years have made it possible to visualize cells
in the living functioning kidney. The main breakthrough was the development
and application of multiphoton lasers in intravital imaging. Multiphoton lasers
generate a pulsed laser beam at wavelengths between 700 and 1100 nm in contrast
to conventional laser lines used in confocal microscopy which employ non-pulsed
lasers of defined wavelengths such as 405 nm, 448 nm or 488 nm. Applying a
longer wavelength has several benefits in contrast to short wavelengths: the light is
scattered less by the tissue and thereby allows for deeper tissue penetration and
imaging. Additionally,it is less phototoxic compared to short wavelengths since
it contains less energy. One photon of 800 nm wavelengths has half the energy
compared to one photon of 400 nm wavelengths. To excite a fluorophore such as
the green fluorescent protein (GFP) two photons of 800 nm wavelengths need to
reach the fluorophore simultaneously so that the combined energy is able to excite
the fluorophore. Consequently, the process of excitation itself is already confocal
and therefore no pin hole is needed as in conventional microscopy. Thus, all of the
emitted light can be gathered. The use of ultra-sensitive detectors allows for a
close to maximum collection of the emitted light (see 5.2.7).
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Figure 4: Physical aspects of 2-photon imaging. In 2-photon imaging a pulsed
laser is tuned to a long wavelength of light (800-1000 nm). In contrast to conventional
microscopy (400-600 nm) two photons are needed to excite a fluorophore as the
long wavelength light contains less enegery. This makes the excitation process itself
confocal.
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3.5.2 In vivo imaging of the kidney
In contrast to the groups of Molitoris [76], Peti-Peterdi [75] and others we use an
upright microscope instead of an inverted model. Therefore, we designed a novel
kidney mounting (Fig. 5a) in collaboration with the on-campus company Medres
which allows stabilization and adjustment of the kidney position in the x-, y- and
z-axis. Furthermore, a mouth piece for anaesthesia gas and a heating system to
maintain the body temperature are integrated into the animal mount. For imaging
a cover slip is placed on top of the kidney with slight pressure to facilitate contact
of the water immersion objective with the kidney (Fig 5b).
Figure 5: Equipment for in vivo imaging. a, custom-designed kidney holder.
b, anesthetized mouse with an exteriorized kidney under the microscope.
In vivo imaging of the kidney allows for visualization of tubular structures of
the superficial layers of the kidney cortex, consisting mainly of proximal tubular
sections and some distal tubular sections which can be distinguished by the degree
of auto-fluorescence and structure [77]. Visualization of peritubular structures and
blood flow is achieved by injecting a fluorescently labeled 70 kDa dextran (Texas
Red, tab. 2) (Fig. 6a) which is not filtered, retained in the circulation and thus
labels the vasculature red. In order to visualize glomerular structures, we used
mice in a C57Bl6 background of three to four weeks of age. Due to the young age
and genetic background of the mice glomeruli were situated superficially enough
which is a prerequisite for imaging [78]. In contrast to proximal tubular cells, the
glomerular cells display no auto-fluorescence (Fig. 6b). Injection of 70 kDa dextran
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Texas Red visualizes the capillary loops of the glomerulus (Fig. 6b) and blood flow
of single glomeruli can be monitored during imaging.
green Channel red Channela
b
merge
Figure 6: In vivo imaging of kidney structures. a, cortical tubular structures.
Left: auto-fluorescence of the tubules in the green channel. middle: autofluorescence
of the tubules and labeling of the peritubular bed with Texas Red shown in magenta.
right: merge. b, glomerular structures. left: autofluorecence. middle: labeling of the
glomerular capillary loops using Texas Red (magenta). right: merge. Scale bars: 40
µm.
Using in vivo imaging, functional aspects of the kidney such as filtration can
be observed. Injection of low molecular fluorescent molecules allows monitoring of
the filtration and calculation of the glomerular filtration rate (GFR) of a single
glomerulus. A number of different compounds can be applied to label kidney
structures and cells in the kidney. Injection of fluorescently labeled compounds
such as Lectin-FITC allows in vivo detection of the capillary walls without the
necessity for a transgenic mouse line. Compounds such as propidium iodide (PI)
or AnnexinV can be used to label necrotic or apoptotic cells.
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4 Objectives
4.1 Calcium signaling in podocytes upon Angiotensin II stimulation
Studies using podocyte cell culture and isolated glomeruli revealed that podocytes
respond to AngII stimulation with calcium transients [56, 79] and overactivation
of RAAS has been associated with kidney damage [41]. We therefore aimed to
investigate the role of AngII-mediated calcium transients in vivo using intravital
microscopy. To answer the fundamental question of how podocytes react upon
stimulation with AngII in their specific environment in vivo, we employed mice
expressing GCaMP3 exclusively in podocytes and stimulated them with AngII to
induce calcium signaling.
To expand our experiments towards glomerular disease, we used two established
disease models, Adriamycin nephropathy and deletion of podocin, to understand
the pathophysiological role of AngII-mediated calcium signaling. Additionally, we
used a Trpc6 knock out mouse line to assess its role in AngII-mediated calcium
transients. Finally, we conducted quantitative proteomic analyses to reveal the
underlying mechanisms responsible for the observed increase in responsiveness to
AngII.
4.2 Purineric calcium signaling in podocytes
Studies using cell culture and isolated glomeruli suggested that ATP triggers calcium
transients in podocytes [27]. Furthermore, Burford et al. [75] demonstrated that
ATP plays a role in mediating podocyte injury signals between podocytes. We aimed
to investigate the contribution of ATP signaling in various cell populations in the
kidney. We therefore used mice expressing GCaMP3 in endothelial cells, proximal
tubular cells and podocytes to validate the role of ATP in calcium signaling in the
nephron. We performed bolus injection of ATP at different doses and recorded
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and analysed the induced calcium transients. Additionally we performed ex vivo
experiments to unravel differences between in vivo and ex vivo models.
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5 Material and methods
5.1 Material
Table 2: Chemicals and reagents
Chemicals/Reagents Provider Catalog Number
4 % Para Formaldehyde (PFA) Sigma P6148
37 % Formaldehyde Th. Geyer 4979.1
Acetic Acid Sigma 49199
Adriamycin (ADR) Teva 45963-0733-55
Agarose Sigma A9539
Ammonium persulfate (APS) Applichem A1142,0250
Ammonium sulfate Carl Roth 3746
Angiotensin II Sigma A9525
Bovine Serum Albumin (BSA) Sigma A9418
Bromophenol blue Carl Roth A512
Collagenase Type 1A Sigma C-9891
Coomassie Brilliant Blue BioRad 161-0400
Dimethyl sulfoxide (DMSO) AppliChem A3672,0100
Dithiothreitol (DTT) Thermo Fisher R0862
dNTPs (100 mM) Thermo Fisher R0182
Dynabeads M-450 Tosylactivated Thermo Scientific 14203
Ethanol 99 % Applichem A5007
Ethanol absolute Carl Roth 9065
Ethidiumbromide solution (1 %) Carl Roth 2218
Ethylenediaminetetraacetic acid dis-
odium salt dihydrate (EDTA)
Sigma 60-00-4
Continued on next page
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Fluo-4, AM Thermo Fisher F14217
FuraRed, AM Thermo Fisher F3021
GeneRuler 50bp DNA Ladder Thermo Fisher SM0372
Glycerol Carl Roth 3783
Isoflurane Piramal Healthcare 103058
Isopropanol Carl Roth 5752.3
KCl Sigma P5405
Ketavet R© (100 mg/ml) Pfizer
KH2PO4 Sigma P5655
Loading Dye Solution (6X) Thermo Fisher R0611
Losartan Sigma 124750-99-8
Mayer’s hematoxylin AppliChem A0884
Methanol Carl Roth 4627
MgCl2 Merck 1.05833.0250
N,N,N’,N’-
tetramethylethylenediamine
(TEMED)
Carl Roth 2367
Normal Saline (0.9 %) Fresenius Kabi
Ortho-phosphoric acid (85 %) Roth 6366.1
Paraformaldehyde (PFA) Sigma P6148
PD123319 Cayman Chemicals/
Bertin Pharma
136676-91-0
Polyacrylamide Carl Roth T802
RNase-free water Ultra Pure Thermo Fisher 10977-035
Rompun R© 2% Bayer 102596
Sesame oil Sigma S3547
Continued on next page
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Sodium dodecyl sulfate SDS (For
transfer buffer)
AppliChem A2263, 0500
Sodium acetate Merck 6268
Sodium chloride (NaCl) Sigma S5886
Sodium deoxycholate Sigma D6750
Tamoxifen Sigma T5648
Temgesic (1 ml zu 0,3 mg) RB Pharmaceuticals
Limited
Texas Red Thermo Scientific D-1830
Triton X-100 Applichem A4975,1000
Trypsin Sigma T6567
Urea Sigma U1250
Water PCR Reagent Sigma R2523
Table 3: Solutions and buffers
Solution Composition
Anesthetic and analgetic Solu-
tion
6.8 ml 0.9 % NaCl
1 ml Ketavet (100 mg/ml)
0.4 ml Rompun 2 %
Base Solution (50X) 12.5 ml NaOH (5N)
1 ml EDTA (0.5 M)
36.5 ml ddH2O
Base Solution (1X) 0.5 ml Base solution (50X)
24.5 ml ddH2O
Continued on next page
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pH 12
Coomassie staining solution 756.14 mM H8N2O4S
520.4 mM ortho-phorphoric acid
117.09 mM Coomassie brilliant
970ml H2O
activate with 20 % (v/v) Ethanol
Fixing solution 250 ml Isopropanol
100 ml Acetic acid (100%)
1 L H2O
HBSS Buffer 1 (10X) 53 mM KCl
4.4 mM KH2PO4
1.36 M NaCl
41.6 mM NaHCO3
5.6 mM Na2HPO4
55.5. mM Glucose
HBSS Buffer 2 (10X) 13 mM CaCl2 x 2H2O
4.9 mM MgCl2 x 6H2O
4.3 mM MgSO4 x 6H2O
HBSS Buffer (1X) 100 ml HBBS Buffer 1 (10 X)
100 ml HBSS Buffer 2 (10 X)
800 ml H2O
Lysis Buffer 8 M Urea
50 mM Ammonium bicarbonate
Neutralization Solution (50X) 100 mM Tris-HCl
in 50 ml H2O
Neutralization Solution (1X) 0.5 ml stock sol. 50X
Continued on next page
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24.5 ml H20
pH 5
Resolving Gel 750 mM Tris
10% (v/v) PAA
0.2% (w/v) SDS
Running Buffer 25 mM Tris
192 mM Glycine
0.1% (w/v) SDS
Stacking Gel 250 mM Tris
5% (v/v) PAA
0.2% (w/v) SDS
pH 6.8
TAE (1X) 40 mM Tris
20 mM Acetic Acid
1 mM EDTA
pH 8.5
Bath Solution 145 mM NaCl
2 mM CaCl2
4.5 mM KCl
2 mM MgCl2
10 mM HEPES
→ pH 7.35 (adjusted with NaOH)
Calcium Recording Solution 125 mM NaCl
2 mM CaCl2
4.5 mM KCl
2 mM MgCl2
Continued on next page
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20 mM HEPES
10 mM Glucose
→ pH 7.4 (adjusted with NaOH)
Table 4: List of materials
Material Company Catalog Number
1.5 ml Epis Sarstedt 72.706.201
2 ml Epis Sarstedt 72.691
Biosphere Filter Tip 10 µl, sterile Sarstedt 70.1116.210
Biosphere Filter Tip 1000 µl, sterile Sarstedt 70.762.211
Biosphere Filter Tip 200 µl , sterile Sarstedt 70.760.211
Combs (10 well, 1 mm) for acrylamide gels Thermo
Fisher
NC3010
Combs (12well, 1 mm) for acrylamide gels Thermo
Fisher
NC3012
Coverslip (18 x 18 mm) LH22.1 Roth
Dyna Mag 2 (Magnet) Thermo
Scientific
12321D
Gel cassette (1 mm) Thermo
Fisher
NC2010
Hamilton Pipette 50 µl Hamilton 705
Hypodermic needle (30 gauge) BD AN-3013R
Needle (27 gauge) BD ND635
Nitrile gloves S Abena 224685
PCR Soft-lids ml 8 Tubes/Flat Caps Sarstedt 65989002
Continued on next page
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PCR Soft-tubes 0.2 ml 8 Tubes/Flat Caps,
clear
Sarstedt 72985002
Polyethylene tubing (PE10) Braintree
Scientific
B-PE-10-100FT
Pipetboy Integra
Bio-
sciences
1550
Pipettes GILSON P2, P10, P20,
P200, P1000
Polypropylene conical tube (15 ml) Greiner 227261
Polypropylene conical tube (50 ml) Greiner 188271
Syringe (PlastipakTM 1 ml) BD 7392/2007
Syringe (10 ml) BD 309110
TipOne (0.1-10 µl XL), sterile Starlab S1110-3810
TipOne (101-1000 µl graduated), sterile Starlab S1111-6811
TipOne (1-200 µl beveled), sterile Starlab S1111-1816
TipOne Pipette Tip 10µl, refill Starlab S1111-3700
TipOne Pipette Tip 1000µl, refill Starlab S1111-6700
TipOne Pipette Tip 200µl, refill Starlab S1111-1700
Suture material(6-0 USP) Resorba 88153
Surgical suture (5-0-USP) Resorba H2F
Table 5: Equipment
Equipment Company
Bandpass filter 525/50 Leica Microsystems
Detectors (NDD HyD) Leica Microsystems
Continued on next page
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Heating system (water) (KS 92-1) Medres, medical research company
GmbH
Kidney Holder (custom made) Medres, medical research company
GmbH
Knock out box Medres, medical research company
GmbH
Multiphoton laser (Chameleon Vi-
sion II)
Coherent
Infusion Pump (AL-1000) World Precision Instruments (WPI)
Isoflurane Vapor Dräger
Hair Trimmer Contura (HS61) Wella
Scale Imaging Room OHAUS
Scale Hood Kern PCB
Stereo Microscope M80 Leica Microsystems
TCS SP8 MP-OPO Leica Microsystems
Table 6: Software
Software Company
Excel Microsoft
Imaris Bitplane
ImageJ National Institute of Health (NIH)
LasX Leica Software
LaTeX LaTeX Program Team
Prism GraphPad
Illustrator Adobe
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Table 7: Genotyping primers
Primer name Sequence (5’ to 3’)
Beta globin fp TGCTCACACAGGATAGAGAGGGCAGG
Beta globin rp GGCTGTCCAAGTGATTCAGGCCATCG
Cre fp GCATAACCAGTGAAACAGCATTGCTG
Cre rp GGACATGTTCAGGGATCGCCAGGCG
mTmG wt fp CTCTGCTGCCTCCTGGCTTCT
mTmG wt rp CGAGGCGGATCACAAGCAATA
mTmG tg rp TCAATGGGCGGGGGTCGTT
Nphs2 lox2 fp CCAGCATCCCATTAGATAGATGAGG
Nphs2 lox2 rp GCATCCAAATGATCAGAGTTCCCAGG
TRPC6 E7 fp CAGATCATCTCTGAAGGTCTTTATGC
TRPC6 E7 rp TGTGAATGCTTCATTCTGTTTTGCGCC
TRPC6 IF fp GGGTTTAATGTCTGTATCACTAAAGCCTCC
Pgk rp ACGAGACTAGTGAGACGTGCTACTTCC
Table 8: Kits
Kit Company Catalog Number
Go Taq Flexi DNA Polymerase 5U/µl Promega M7808
REDTaq R© ReadyMixTM PCR Reaction Mix Sigma R2523
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5.2 Methods
5.2.1 Genetic mouse models
In order to visualize cytosolic calcium levels in different cell types of the kidney,
calcium reporter mouse lines (Tab. 9) were crossed to different cell specific Cre
lines (Tab. 10). GCaMP3 is a calcium sensor protein in which the green fluorescent
protein (GFP) is fused to the Ca2+-binding protein calmodulin [80]. Podocyte
specific expression was achieved by crossing GCaMP3fl/fl with Pod:cre mice [81],
generating Pod:cre GCaMP3fl/fl mice. To delete the transient receptor potential
cation channel 6 (Trpc6) these mice were crossed with a conventional Trpc6 knockout
line [82] generating a Pod:cre GCaMP3fl/fl Trpc6KO/KO line. The generated mouse
lines were maintained in a C57BL6 background. Further, Pod:cre GCaMP3fl/fl mice
were bred with Podocinfl/fl mice carrying floxed podocin alleles [18] resulting in the
generation of Pod:cre GCaMP3fl/fl Podocinfl/wt or Pod:cre GCaMP3tfl/fl Podocinfl/fl
mice. These mice were kept in a mixed Sv129/C57BL6 background. To express
GCaMP3 in endothelial cells, GCaMP3fl/fl mice were crossed with Tie2:cre animals
[83] resulting in Tie2:cre GCaMP3fl/fl animals respectively. To achieve GCaMP3
expression in the entire nephron the Pax8:cre mouse line [84] was used, genereating
Pax8:cre GCaMP3fl/fl. Table 9 and 10 list all mouse lines used in this thesis.
Table 9: Mouse lines
Mouse line use Publication
GCaMP3fl/fl visualization of cytosolic Ca2+ levels Zariwala et al.
(2012)
Trpc6KO whole body deletion of the Trpc6 ion
channel
Dietrich et al.
(2005)
Continued on next page
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Podocinfl/fl cell-type specific deletion of podocin Mollet et al.
(2009)
Table 10: Cre mouse lines
Mouse line use Publication
Pod:cre Cre expressed in podocytes Moeller et al.
(2003)
Pax8:cre Cre expressed in the entire nephron Bouchard et al.
(2002)
Tie2:cre Cre expressed in endothelial cells Kisanuki et al.
(2001)
5.2.2 Sample preparation of DNA for genotyping
DNA samples of mice (ear tags) were provided by the in house animal facility.
Samples were frozen at -20 ◦C until DNA preparation. For DNA extraction 75 µl
of Base solution (1 X) (Tab. 3) were added to the ear tag and boiled at 95 ◦C for
25 minutes, followed by five minutes on ice. Then, 75 µl of neutralization solution
(1 X) (Tab. 3) were added [85]. Samples were run on a 2 % agarose gel and stored
at 4 ◦C until the genotyping was conclusively finished.
5.2.3 Polymerase chain reaction for genotyping
For genotyping the Go Taq Flexi DNA Polymerase 5U µl or the REDTaq R©
ReadyMixTM PCR Reaction (Tab. 8) were used following the companies protocols.
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Table 7 lists all primers used for genotyping. Table 11 lists the specific reaction
composition and table 12 list the specific cycling conditions for each genotyping.
For all PCRs 2.5 µl (∼ 50 ng) of DNA were used (see 5.2.2).
Table 11: Reaction composition
Gene Reaction Mix
Cre 5 µl ddH2O
1.25 pM Beta globin fp
1.25 pM Beta globin rp
1.25 pM Cre fp
1.25 pM Cre rp
12.5 µl REDTaq R© ReadyMixTM
˜ 50 ng DNA
GCaMP3 6.8 µl ddH2O
25 pM mTmG wt fp
17 pM mTmG wt rv
33 pM mTmG tg rv
12.5 µl REDTaq R© ReadyMixTM
˜ 50 ng DNA
Podocin 13.1 µl ddH2O
1.25 pM Nphs2 lox2 fp
1.25 pM Nphs2 lox2 rp
1.5 mM MgCl2 (25 mM)
0.2 mM dNTP (25 mM)
2 Units Go Taq Flexi DNA Polymerase
˜ 50 ng DNA
Trpc6KO 9.6 µl ddH2O
Continued on next page
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1.5 pM TRPC6KO E7 fp
1.5 pM TRPC6KO E7 rp
1.5 pM TRPC6KO IF rp
1.5 pM Pgk rp
1.5 mM MgCl2 (25 mM)
0.2 mM dNTP (25 mM)
2 Units Go Taq Flexi DNA Polymerase
˜ 50 ng DNA
Table 12: Genotyping cycler conditions
Gene Step Temperatur [◦C] Duration [s] Number of cycles
Pod:cre
1 94 180
2 94 45
3 59 60
4 72 45 goto step 2, 30 repeats
5 72 600
6 15 ∞
mtmg
1 94 180
2 94 30
3 61 60
4 72 60 goto step 2, 35 repeats
5 72 120
6 15 ∞
Continued on next page
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Podocin
1 94 300
2 94 30
3 62 45
4 72 30 goto step 2, 40 repeats
5 72 420
6 15 ∞
Trpc6KO
1 94 180
2 94 30
3 56 45
4 72 90 goto step 2, 45 repeats
5 72 600
6 15 ∞
5.2.4 Perfusion of mice
The animal was anesthetized using the anesthetic solution (Tab. 3) with a dose of
10 µl/g body weight (i.p.). After complete loss reflexes (negative paw pinch) the
mouse was fixated on a Styrofoam surface. The chest cavity was opened and the
heart was exposed. A 30 gauge needle was carefully inserted into the left ventricle
and a the right ventricle was cut using a scissor. Manual perfusion with PBS from
a 20 ml syringe was started. As soon as the liver became pale the syringe was
changed to one containing 10 ml of 4 % para formaldehyde. Afterwards the kidneys
were removed and processed for histological staining.
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5.2.5 Induction of Adriamycin nephropathy
Kidney disease was induced in 4 weeks old mice using Adriamycin (ADR) [86]
[87]. Prior to injection of Adriamycin a urine sample was collected. Anesthesia/
analgesia was performed with Isoflurane/ Buprenorphine (0.05 mg/kg). The mouse
was transferred to a warmed surgery stage and the right jugular vein was dissected
via a longitudinal incision of ∼ 1 cm to the right next to the mid line of the neck.
25 mg/kg ADR or normal saline in control animals was administered via a catheter
(PE10) placed into the jugular vein. Positioning of the catheter was checked by
injecting a small volume of normal saline. After injection of ADR, the incision
was closed with simple interrupted stitches and the animal was allowed to recover.
The day of injection was counted as day 1 of the treatment. On the following days
the mice were monitored for weight changes and urine was collected. Successful
induction of Adriamycin nephropathy was confirmed by detection of proteinuria on
commassie gels (Tab. 5.2.13). On day 5 mice underwent in vivo imaging.
5.2.6 Preparation for in vivo imaging
Anesthesia/ analgesia was performed with Isoflurane/ Buprenorphine (0.05 mg/
kg). The mouse was shaved on the left flank using a hair trimmer (Tab. 5). The
mouse was then transferred to a warmed surgery stage and the right carotid artery
was dissected via a longitudinal incision under the chin. The tissue above the
trachea was prepped and the right carotid artery isolated. The carotid artery was
closed at the cranial end by a knot (6-0 USP, silk) and a second knot was prepared
for fixation of the catheter (Tab. 4). The artery was clamped caudally creating an
approximately 0.8-1 cm long section without blood flow. Now a small incision into
the artery was made using a scissor. The catheter was inserted into the carotid
artery and fixed with two threads. The incision was closed with 2 to 3 interrupted
stitches. The mouse was now positioned on its right side. Then the left kidney was
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exteriorized by an approximately 4-8 mm long incision at the left flank cutting
through the skin and the peritoneal wall. The mouse was placed on the heated
imaging stage and the kidney was immobilized with a custom-build kidney holder
(Tab. 5). A cover slip (Tab. 4) was placed on the kidney with minimal pressure
and the animal was transferred to the microscope. A 70 kDa dextrane Texas Red
(Tab. 2) was administered to label the blood circulation in red.
5.2.7 In vivo imaging
In vivo imaging was carried out using an upright multiphoton microscope (MPM)
(Tab. 5) with a 25x water immersion objective with a numerical aperture of 0.95.
The multiphoton laser was tuned to a wavelength of 940 nm and the signal was
recorded using non descanned hybrid detectors and a bandpass filter 525/50 (Tab.
5). The following image settings were used: bi-directional scanning mode, speed of
600 Hz and a line average of two. As resolution 512x512 pixels were used. Time
series were recorded with a frame rate of 1 image/second. Z-Stacks were recorded
with 2 µm per plane.
5.2.8 Laser induced injury
Laser induced injury was done similarly as previously described by Burford et al.
in 2014 [75]. In brief, the Live Data Mode provided by the Leica software was used.
First, a 10 second time series was defined before the laser induced injury, which
serves as a baseline measurement of the GCaMP3 fluorescence. Then, a second
time series was defined during which the laser zoomed in to a pre-defined position
in the glomerulus causing the laser injury. The degree of induced laser injury was
monitored and stopped manually. Subsequently the image zoomed out again and
the resulting calcium wave was recorded.
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5.2.9 Infusion of AngII/ Losartan/ PD123319
In order to administer different compounds during imaging the vascular access via
the arterial catheter was used. To ensure steady infusion an infusion pump was
used for administration. All infusion were done with a rate of 10 µl/min. The used
doses for different substances are shown in table 13. Infusion of AngII was stopped
as soon as a signal was recorded or 80 seconds elapsed without a signal. Between
two infusions a 10 minute time interval was included, to ensure circulating AngII
to be degraded. In order to test the effects of the AT1R inhibitor PD123319 and
the AT2R inhibitor Losartan the same glomerulus was imaged before and after
administration of an inhibitor.
Table 13: Substances and doses for infusion
Substance Dose
Angiotensin II 10 or 100ng/g
Losartan 10 mg/kg BW
PD123319 10 mg/kg BW
5.2.10 Isolation of glomeruli
Prior to glomerular preparation the animal was killed by cervical dislocation and
the kidneys were removed together with the connecting vessels and the aorta.
Kidneys were transferred to a dish filled with ice-cold HBSS buffer (Tab. 3). The
aorta was prepped, cut longitudinally and a 27 gauge needle was inserted into the
arteria renialis. The kidneys were perfused with tosylactivated magnetic beads (20
µl beads/ml/kidney) (Tab. 4). After successful perfusion the kidneys were either
processed for calcium imaging experiments (see 5.2.11) or for mass spectrometry
(see 5.2.12).
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5.2.11 Calcium Imaging of isolated glomeruli
After successful perfusion, kidneys were decapsulated and minced using a scalpel.
The tissue was incubated with collagenase 1A (1 mg/ml) for 20 minutes at 37
◦C. Subsequently, the tissue was homogenized by gently pipetting up and down
with a 1000 µl pipet tip with the tip cut off. The generated kidney solution was
transferred onto a 100 µm sieve and the solution was gently pushed through using
the cone of a 5 ml syringe. The sieve was washed with 3-4 ml of cold HBSS. The
flow-through was poured on top of a fresh 100 µm sieve. After passive passage
of the solution, the sieve was washed with 3-4 ml of cold HBSS. The resulting
solution (10 - 12 ml) containing the glomeruli was transferred into 2 ml eppis
which were put in a magnetic holder. This allowed for the glomeruli, containing
magnetic beads, to concentrate at the magnet. The liquid was removed leaving
the isolated glomeruli on the magnet. The glomeruli were washed of the magnet
with 1 ml HBSS and collected from the different tubes. Finally the glomeruli
were washed in 1 ml of HBSS using the magnet and finally dissolved in 1 ml of
RPMI medium containing 5 % bovine serum albumin (BSA). In order to load the
cells with a calcium sensitive dye we incubated the glomeruli with Fluo4. 1 µl of
Fluo4 (dissolved in DMSO, Stock: 5 µM) was added to the glomeruli solution. The
eppi was covered with aluminum foil and the glomeruli were incubated at room
temperature for 30 minutes on a shaker. After incubation, the medium containing
the calcium dye was removed by using the magnet, and the isolated glomeruli were
dissolved in 150-200 µl of RPMI medium containing 5 % BSA.
5.2.12 Preparation of isolated glomeruli for mass spectrometry
These experiments were done in cooperation with Dr. Markus Rinschen. In brief,
isolated glomeruli were snap-frozen in liquid nitrogen and stored at -80 ◦C. Pelleted
glomeruli were lysed in 8M urea, reduced and alkylated as previously described
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[88]. Then, 25 µg of protein lysates were digested using trypsin. After acidification
using 4 % formic acid, peptides were cleaned up using stop and go extraction tips
(STAGEtips) as described previously [89].
5.2.13 Coomassie proteinuria gel
In order to check for albuminuria/ proteinuria in spot urine of mice injected with
Adriamycin (Section 5.2.5) or carrying a knock out of podocin the following sample
was prepared: 2 µl urine, 8 µl H2O, 10 µl 2x loading buffer.
For gel electrophoresis a 10 % poly acrylamide gel was used. As a control a
bovine serum albumin (BSA) in defined amounts (1 and 10 µg) were loaded. The
gel was run first at 70 V for 30 minutes followed by 35 mA for 1 h 45 minutes. The
gel was then transferred into the fixing solution (tab. 3) for 30 minutes at RT on
a shaker. The gel was rinsed with water and then transferred into the coomassie
staining solution (tab. 3) and stained over night at RT on the shaker. Destaining
was done by transferring the gel into water and destaining it until only the protein
bands remained blue.
5.3 Data analysis
5.3.1 Percentage of podocyte area showing a calcium signal
For data analysis, only glomeruli showing a calcium signal were analyzed. Data
analysis was conducted using FIJI (Table 6). The FIJI PlugIn "Correct 3D
Drift" was used for motion correction to minimize shifting in the time series due to
breathing, changes in blood flow and effects of systemic AngII administration. After
successful motion correction a new registered image file is generated. Measurements
where the registration failed were not analyzed. Subsequently a Z-projection with
average intensity was done reducing the frames of the time series to one frame
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allowing the measurement the total podocyte area. In a next step a maximum
Z-Projection was done to measure podocyte area showing a calcium signal.
5.3.2 Measurement of signal duration
After motion correction with the FIJI PlugIn "Correct 3D Drift" the duration of
single podocyte calcium signals was determined. The signal duration as determined
by the time between GCaMP3 baseline fluorescence to a rapid increase in GFP
fluorescence and back to GCaMP3 baseline fluorescence. The baseline fluorescence
was thereby defined as the average GCaMP3 fluorescence before AngII infusion.
5.3.3 Counting of Podocytes showing a calcium signal
Podocyte number was determined by manual podocyte counting using the FIJI
(Tab. 6). First the FIJI PlugIn "Correct 3 D Drift" was used reducing the shifting
caused by breathing artifacts. Then a maximum Z-Projection was carried out
which reduced the 180 frames of the time series to a single frame, thus excluding
any podocyte from being counted twice.
5.3.4 Analysis of nLC-MS/MS and bioinformatics analysis
Analysis of the mass spectrometry data was done by Dr. Markus Rinschen. In brief,
peptides were separated using nanoflow liquid chromatography (nLC) followed by
a tandem mass spectrometry (MS/MS) approach. After nLC the peptides were
sprayed into a Quadrupole-Orbitrap hybrid mass spectrometer (QExactive plus,
Thermo) using a 1 h gradient and mass spectrometer configurations as previously de-
scribed [89]. Bioinformatic analysis was performed using MaxQuant 5 and Perseus
v 1.5.5.3 6 essentially as previously described [90]: A complete database from mouse
without isoforms was used (uniprot, downloaded January 2017) and the label-free
quantification (LFQ) option was enabled. LFQ values were log2 transformed and
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samples with less than 50 % expression in the global protein expression matrix
were removed. The significance analysis of microarray (SAM) approach initially
developed by Tusher et al. [91] was used to define significantly altered proteins and
correct for multiple testing between treated and untreated samples. False discovery
rate (FDR) was 0.05, s0 was 0.1. Proteins were annotated with gene ontology
(GO) terms and uniprot keywords using the Perseus annotation package. The mass
spectrometry proteomics data have been deposited to the ProteomeXchange Con-
sortium via the PRIDE [92] partner repository (http://www.ebi.ac.uk/pride) with
the dataset identifier PXD007717. Submission details: Project Name: Doxorubicin
treated mouse and glomerular proteome; Project accession: PXD007717; Username:
reviewer84945@ebi.ac.uk; Password: 0dOrZwNh.
5.4 Statistics
Statistical calculations were done using Graph Pad PRISM. Comparison of two
groups was done by two-tailed student’s t-test with a confidence interval of 95
%. Comparison of more than two groups was done with One-Way ANOVA with
Tukey’s Multiple Comparison Test with a significance level alpha of 0.05.
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6 Results
6.1 AngII mediated calcium signaling in podocytes
6.1.1 Expression of GCaMP3 in podocytes.
In order to study calcium signals in podocytes we made use of a transgenic mouse
line expressing GCaMP3 from the Rosa26 locus upon excision of a lox-stop-lox
casette by Cre recombination. GCaMP3 is a fusion protein consisting of the
calcium binding protein calmodulin and the Green Fluorescent Protein (GFP),
whose fluorescence increases upon elevation of intracellular cytosolic calcium levels
[80]. In order to achieve podocyte specific expression we crossed GCaMP3fl/fl mice
with Pod:cre (Nphp2 :cre) mice (see 5.2.1). Expression of GCaMP3 was visualized in
vivo using intravital imaging of the kidney. Since we used an adjustable Titanium-
Sapphire laser for two-photon microscopy to enable deep tissue imaging of the living
kidney, we performed a lambda scan and determined a laser wavelength of 940
nm as best compromise between penetration depth and brightness of the calcium
indicator GCaMP3. Figure 7 shows the expression of GCaMP3 in podocytes.
To monitor blood flow and perfusion of the imaged glomerulus we injected a 70
kDa dextrane coupled to a red fluorescent probe (Texas Red). Due to its size
the fluorescently labelled dextrane is retained in the blood circulation and is not
filtered.
Texas RedGCaMP3 merge
Figure 7: Expression of GCaMP3 in podocytes in vivo. left: GCaMP3
florescence, middle: labelling of the vasculature using 70 kDa dextrane Texas Red,
right: merge. Scale bar: 40 µm.
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6.1.2 Calcium signaling in podocytes upon Angiotensin II stimulation
Dysregulation of calcium signaling pathways has been associated with podocyte
injury [16]. Podocyte cell culture studies and experiments using isolated glomeruli
have shown that stimulation with Angiotensin II (AngII) can elict calcium transients
podocytes [93, 55, 56]. However, calcium signaling in podocytes upon AngII
treatment has not been shown in vivo. In order to induce calcium signals in vivo,
we infused Angiotensin II (AngII) using an infusion pump with a speed of 10 µl
per minute (see 5.2.9). Out of 29 imaged glomeruli only one showed a calcium
signal at a dose of 10 ng/g/min AngII (Figure 8 a). Infusion of normal saline alone
(vehicle), did not induce any calcium transients. An increase of the AngII dose to 100
ng/g/min (10 µl/minute) triggered a calcium signal in 21 % of the imaged glomeruli
(Figure 8 b). One of the main physiological functions of AngII is regulation of the
single nephron glomerular filtration rate (GFR). Thereby AngII acts on the efferent
arteriole mediating constriction of the capillary to maintain filtration pressure in
the event of drops of the systemic blood pressure. In higher doses it results in
reduced blood flow and a swelling of the glomerular capillary network. During
administration of AngII we observed this described effect indicating that the chosen
dose of AngII was sufficient even though it induced unstable imaging acquisition.
In order quantify the number of podocytes showing a calcium signal in an
unbiased fashion we chose to calculate the percentage of the area of GCaMP3
fluorescence showing an increase upon stimulation with AngII and thus indirectly
representing the number of podocytes showing a calcium signal (see 5.3.1). Therefore
only measurements showing a calcium signal were analyzed, completely excluding
the groups with infusion of normal saline since they did not show a signal in any
measurement. The quantification showed that a mean of 12 % area of GCaMP3
fluorescence showed calcium signal at the dose of 100 ng/g/min. Figure 8c shows
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a representative time series of an animal infused with AngII (100 ng/g/min).
Podocytes showing a calcium signal are indicated by arrow heads.
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Figure 8: Angiotensin II induces calcium transients in only a small frac-
tion of podocytes in vivo. a, Percentage of glomeruli of Pod:cre GCaMP3fl/fl
(control) animals showing a calcium signal in at least one podocyte upon infusion
of normal saline (normal saline) (n=3), AngII (10 ng/g/min, n=5) or AngII (100
ng/g/min, n=13). Numbers above bars indicate: glomeruli showing a calcium signal
/ total number of glomeruli imaged. b, Percentage of podocyte area responding with
a calcium signal upon AngII stimulation is depicted for the same animal groups as in
(a). control + 10ng/g/min AngII (3.7 %, signal in only one glomerulus analyzed),
control + 100 ng/g/min AngII (mean=12±4.5 %, signal in 14 glomeruli analyzed). c,
Representative time series of a glomerulus (green channel shown in false color code)
during infusion of AngII (100 ng/g/min, infusion time: 43 seconds). t=1 s shows the
glomerulus before infusion. Arrow heads indicate podocytes showing a calcium signal.
mean=SEM, n=number of mice, Scale bar: 40 µm.
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6.1.3 Ex vivo stimulation of podocytes with AngII
Additionally we performed ex vivo experiments using isolated glomeruli in an effort
to analyze the observed calcium transients in more detail. Unfortunately we could
not use our transgenic mice expressing GCaMP3 selectively in podocytes (Pod:cre
GCaMP3fl/fl) since the fluorescence of the calcium indicator was completely dimin-
ished after the isolation process (data not shown). We therefore loaded glomeruli
with Fluo4, a commercially available calcium indicator (see 5.2.11). Similar to
GCaMP3, the fluorescence of Fluo4 increases upon elevation of intracellular calcium
levels. We then stimulated isolated glomeruli with either 10 or 100 µM AngII
using a perfusion system and measured changes in fluorescence intensity over time.
Comparable experiments have previously been published using rat and mouse
glomeruli [56, 57, 79]. Figure 9a shows representative images of a glomerulus loaded
with Fluo4 and stimulated with 100 µM AngII. An increase in fluorescence can be
observed in a small fraction of labelled cells as indicated by the arrow heads.
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Figure 9: Isolated glomeruli show a low responsiveness to AngII ex vivo
a, Representative images of a glomerulus loaded with Fluo4 and stimulated with
100 µM AngII (1 ml/min). Arrow heads indicate cells with increased fluorescence.
Green channel is shown in false colors. b, Relative changes in fluorescence (Fmax/
F0) measured in response to 10 µM (n=31) (red line) or 100 µM (black line) (n=66)
AngII. Start of infusion at t=50 s) n=number of cells analyzed, scale bar: 20 µm.
Quantification of the changes in fluorescence intensity over time (Fmax/ F0) as
depicted in Figure 9b indicates that both doses of AngII (10 or 100 µM) induced
an increase in intracellular calcium while the effect lasted longer with the higher
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dose. In our hands the elicited calcium transients did not prove themselves as
reproducible as previously published [56, 57, 79].
Since the isolation protocol involves digestion of the ex vivo perfused kidney by
collagenase and several sieving and washing steps we checked the viability of the
isolated glomeruli by performing Propidium iodide (PI) staining (Figure 10 a).
Therefore, the isolated glomeruli were incubated for 5 minutes with 5 µM PI
solution. Finally, the PI positive nuclei were counted and revealed a mean of 29
positive nuclei per glomerulus (Figure 10 b).
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Figure 10: Isolated glomeruli show a high number of propidium iodide
positive nuclei. a, Representative images of a glomerulus stained with Propidium
ioddide (magenta). b, Quantification of the number of PI positive nuclei with a mean
of 29 nuclei per glomerulus. n=219, scale bar: 40 µm.
Since some nuclei stained positive are located at positions usually occupied
by podocytes in the glomerular architecture it can be speculated that podocytes
undergo some kind of damage during the isolation process process resulting in
nuclear uptake of Propidium iodide.
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6.1.4 Adriamycin nephropathy as model of kidney disease
Since misregulation of intracellular calcium levels has been shown to play a role
in kidney disease we utilized a chemically induced kidney disease model to induce
podocyte injury (see 5.2.5). Adriamycin (ADR) nephropathy was induced by
intravenous injection of 25 mg/kg ADR which induces acute podocyte injury
[86]. Successful induction of kidney disease was controlled by the analysis of spot
urine for the presence of proteinuria (Figure 11 a). Of note, the animals did
not show equal amounts of protein in the urine. This could be due to the spot
urine sample collected or to the degree of disease induction. Furthermore we
performed histological analysis using Periodic acid Schiff (PAS) staining to check
for glomerulosclerosis. Figure 11b shows representative images for control and ADR
treated mice. The latter shows pronounced extra cellular matrix depositions in the
glomerulus and proteinuria in the Bowman’s capsule indicated by the asterisk (*).
The arrow heads indicate positions of abnormal contact between podocytes and
the Bowman’s capsule [5, 94].
1 10
BSA (μg)
75
kDa
#1 #2 #3 #3#2#1
control ADR
control Adriamycina b
*
M
Figure 11: Adriamycin induced nephropathy as a model for podocyte
injury. a, Identification of proteinuria in spot urine (2 µl) of 3 control and 3 ADR
treated animals 5 days after disease induction on a coomassie gel. Bovine serum
albumin (BSA) was used as standard (1 µg, 10 µg). b, Periodic acid–Schiff (PAS)
staining of paraffin embedded kidney sections of control and ADR treated animals.
Arrowhead indicates contacts between podocytes and the Bowman’s capsule. Asteriks
(*) indicates proteinuria. Scale bar: 40 µm.
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6.1.5 Injury renders podocytes responsive to Angiotensin II
In order to investigate the role of AngII induced calcium transients in injured
podocytes we challenged ADR treated animals with AngII to check if the respon-
siveness is altered in disease. As in untreated animals the AngII response to 10
ng/g/min AngII (10 µl/min) was low as only 7 % of the imaged glomeruli showed
any calcium response (Figure 12 a). Nevertheless, healthy control animals showed
even less signal with only 3 % of glomeruli showing a calcium signal (Figure 8
a). Upon increase of the dose to 100 ng/g/min 41 % of the imaged glomeruli
in the group of ADR showed a calcium signal (Figure 12 a), which is a two-fold
increase compared to control (Figure 8 a). Analysis of podocyte area showed, that
on average 26 % of podocyte area was involved in the calcium transient (Figure
12 b) which is also increased compared to controls (Figure 8 b). Figure 12c shows
representative images of a glomerulus with a strong calcium signal involving almost
all of podocytes of the imaged plane. In summary, podocyte injury leads to an
increase in calcium response upon AngII stimulation and a greater percentage of
podocyte area contributes to the observed calcium signal.
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Figure 12: Angiotensin II-induced calcium signals in podocytes increase
after induction of Adriamycin nephropathy. a, Percentage of glomeruli of
Pod:cre GCaMP3fl/fl animals pre-treated with Adriamycin (ADR) infused with ve-
hicle (n=3), AngII (10 ng/g/min, n=6) or AngII (100 ng/g/min, n=24). Numbers
above bars indicate: glomeruli showing a calcium signal / total number of glomeruli
imaged. b, Percentage of podocyte area responding with a calcium signal upon AngII
stimulation is depicted for the same animal groups as in (a). ADR + 10 ng/g/min
AngII (mean=7±6.4 %, signal in 3 glomeruli analyzed), ADR + 100 ng/g/min AngII
(mean=26±3.1 %, signal in 34 glomeruli analyzed). c, Representative time series of a
glomerulus (green channel shown in false color code) during infusion of AngII (100
ng/g/min, infusion time: 82 seconds). t=0 s shows the glomerulus before infusion.
mean=SEM, n=number of mice. Scale bar: 40 µm.
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To utilize a second approach to quantify the AngII induced changes in intracel-
lular calcium levels, we counted the number of podocytes showing a calcium signal
in control and ADR treated animals. To do so, we generated a t-projection of time
series measurements, which showed a calcium signal upon AngII infusion, thereby
combining 180 frames into a single image. This allowed us to count the number
of podocytes more accurately, since infusion of AngII in most cases resulted in
shifting during image acquisition. In control animals on average only two podocytes
displayed a calcium transient upon stimulation with 100 ng/g/min, while in diseased
animals this number increased significantly to seven podocytes (Figure 13). The
number of podocytes counted is in accordance with measurements of podocyte area
as shown in Figure 8b and Figure 12b. Since the response to Angiotensin II was
consistently more pronounced to 100 ng/g/min in healthy and diseased animals we
chose this dose for all further experiments.
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Figure 13: Number of podocytes showing a calcium signal upon An-
giotensin II infusion. Control + 10 ng/g/min (n=1 with one podocytes reacting
to AngII with a calcium signal in a single measurement). Control + 100 ng/g/min
(n=11, mean=2±0.5). ADR + 10 ng/g/min (n=3, mean=3.7±0.3) and ADR +
100 ng/g/min (n=29, mean=7±1). n=number of glomeruli analyzed. mean=SEM,
statistics: One-way ANOVA Tukey’s Multiple Comparison Test: #p=0.01.
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6.1.6 Deletion of Trpc6 reduces the reponsiveness to AngII
As previous studies have shown that the transient receptor potential channel
6 (Trpc6 ) plays a role in elevating intracellular calcium levels in podocytes we
made use of a whole-body knock-out mouse model. We crossed Trpc6KO/KO mice
with our podocyte specific calcium reporter mouse line Pod:cre GCaMP3fl/fl to
generate Pod:Cre GCaMP3fl/fl Trpc6KO (Trpc6KO) animals (Table 9). As published
previously the loss of Trpc6 did not induces a kidney phenotype in healthy mice
[82].
Upon stimulation of Trpc6KO mice with AngII (100 ng/g/min) we observed that
10 % of the imaged glomeruli showed a calcium signal (Figure 14 a), which is slightly
less than in control animals with 13 % (Figure 8 a). Induction of albuminuria by
pre-treatment of Trpc6KO animals with ADR resulted in an increase of this number
to 25 % (Figure 14 a), which is a reduction compared to Trpc6wt animals treated
with ADR which showed a signal in 41 % of glomeruli (Figure 8 a). Trpc6KO
animals treated with Adriamycin developed comparable levels of proteinuria to
control animals (data not shown). Comparison of podocyte area of untreated
Trpc6KO and Trpc6KO animals pretreated with ADR shows a clear increase (Figure
14 b) which is also represented by the number of podocytes showing a calcium signal
as shown in Figure 14c. Taken together, in our model Trpc6 is partially involved
in mediating Angiotensin II induced calcium currents in podocytes in health and
disease, as we observed a decrease in number of glomeruli showing a calcium signal
and less podocyte area was involved in the calcium signal as compared to ADR
and control animals.
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Figure 14: Loss of Trpc6 reduces calcium transients in podocytes upon
AngII stimulation. a, Percentage of glomeruli showing a calcium signal upon stimu-
lation with with 100 ng/g/min AngII. Pod:cre GCaMP3fl/fl Trpc6KO/KO (Trpc6KO) +
vehicle (normal saline) (n=4), Trpc6KO animals treated with AngII (n=9). Trpc6KO
animals pre-treated with Adriamycin (ADR) and infused with vehicle (n=4) or stimu-
lated with AngII (n=16). Numbers above bars indicate: glomeruli showing a calcium
signal / total number of glomeruli imaged. b, Podocyte area showing a calcium
signal for the same groups as in (a). Trpc6KO (mean=8±3.5 %, signal in 5 glomeruli
analyzed), Trpc6KO ADR (mean=21±4.3 %, signal in 24 glomeruli analyzed). c,
Podocyte number showing a calcium signal. Trpc6KO mean=2.2±0.6 (n=4), Trpc6KO
ADR mean=7.7±2 (n=14). n=number of glomeruli analyzed, student’s t-test: p=0.05,
mean=SEM.
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6.1.7 Loss of Nphp2 induces nephrotic syndrome with an early onset
To investigate if the increased responsiveness of podocytes to AngII after injury
is a general mechanism we used a second disease model. In this model the slit
diaphragm component podocin (Nphp2 ) is deleted specifically in podocytes. To
study the impact of loss of podocin on calcium signaling we generated the following
mouse line: Pod:cre GCaMP3fl/fl Podocinfl/fl (PodpKO) and Pod:cre GCaMP3fl/fl
Podocinfl/wt (PodpHet) (Table 9). Heterozygous loss of podocin did not result in a
phenotype, while homozygous loss resulted in severe glomerular damage. Figure
15a shows that PodpKO mice developed strong proteinuria already at the age of
3-4 weeks while PodpHet mice are healthy. In the histological analysis of paraffin
embedded kidney sections using PAS staining control and PodpHet animals did not
exhibit any glomerulusclerosis, while PodpKO animals showed severe glomerular
sclerosis (Figure 15 b).
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Figure 15: Loss of podocin results in severe glomerular damage. a, Analysis
of proteinuria in spot urine of 3 PodpHet and 3 PodpKO animals using a Coomassie gel.
Bovine serum albumin (BSA) was used as standard (1 µg, 10 µg). b, PAS staining
on paraffin embedded kidney sections (2 µm) of control, PodpHet and PodpKO. Scale
bar: 40 µm.
In vivo imaging of PodpKO animals expressing GCaMP3 in many cases showed
sclerotic glomeruli correlating with impaired glomerular blood flow. Figure 16
shows four glomeruli imaged in a single animal, with each of them showing some
degree of abnormalities as a dilated Bowman’s capsule (Figure 16 a), pathological
changes in podocyte structure, enlarged cell body as indicated by the asterisk (*)
54
6 RESULTS
and elevated calcium levels in podocytes (Figure 16 b-d). Therefore, the observed
pathological changes in PodpKO animals observed by histological analysis (Figure
15 b) can be recapitulated by intravital imaging, while PodpHet animals did not
show any alterations (data not shown).
*
*
a b
c d
GCaMP3 Texas Red
Figure 16: Podocin knock out animals show a severe glomerular pheno-
type in vivo. Representative images of glomeruli using intravital microscopy. a,
Podocytes expressing GCaMP3 show normal morphology and normal perfusion (Texas
Red in magenta) but the Bowman’s capsule is dilated as indicated by the asterisk
(*). b, the shown glomerulus is highly sclerotic with podocytes filling Bowman’s
space. The arrow head indicates a cell with increased calcium levels compared to
neighbouring cells. c, Glomerulus shows a dilated cell body indicated by the asterisk
(*) and cells with elevated calcium levels indicated by the arrow head. d. Two
glomeruli shown next to each other. One (left) shows partly normal morphology and
blood flow, while the second one (right) is completely sclerotic and has almost no
blood flow. Scale bar: 40 µm.
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6.1.8 Increased responsiveness to AngII is a common characteristic of podocyte injury
In order to validate if the observed effect of disease on the responsiveness to acute
AngII treatment is a general mechanism we stimulated PodpKO mice with a dose
of 100 ng/g/min AngII. The homozygous deletion of podocin rendered the cells
responsive to AngII as 59% of the imaged glomeruli in the group of PodpKO showed
a calcium transient (Figure 17 a). This number is even higher than in the model
of Adriamycin nephropathy as shown in Figure 12a. Surprisingly, stimulation of
PodpHet animals resulted in a calcium signal in 36 % of the imaged glomeruli,
which is less than in PodpKO (Figure 17 a). but substantially higher than the
observed response in control animals, even though the PodpHet do not show any
phenotype (Figure 8 a). Measurement of podocyte area showed that in the group
of PodpKO animals a mean of 21 % of podocyte area showed a calcium signal. In
PodpHet animals a mean area of 28 % was measured, the highest percentage of
all studied groups. Figure 17c shows representative images of AngII stimulated
glomeruli of PodpHet and PodpKO mice. In summary, loss of podocin resulted in
a strong responsiveness of podocytes to AngII stimulation. Furthermore, the loss
of one podocin allele already increased the sensitivity to AngII comparable to the
investigated disease models.
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Figure 17: Loss of podocin renders podocytes responsive to AngII in
vivo. a, Percentage of glomeruli showing a calcium signal upon stimulation with
100 ng/g/min AngII in Pod:cre GCaMP3fl/fl Podicinfl/wt (PodpHet) (n=31) and
Pod:cre GCaMP3fl/fl Podicinfl/fl (PodpKO) (n=10) mice. Numbers above bars indicate:
glomeruli showing a calcium signal / total number of glomeruli imaged. b, Percentage
of podocyte area reacting with a calcium signal upon AngII (100 ng/g/min) stimulation
is depicted for the same animal groups as in (a). PodpHet (mean=21±2.5, glomeruli
analyzed=37) and PodpKO (mean=28±3.8, glomeruli analyzed=28). c, Representative
images of PodpHet and PodpKO animals stimulated with AngII. Green channel is
shown in false color code. mean=SEM, student’s t-test: p=0.1649, Scale bar: 20 µm.
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6.1.9 AngII-induced signals are mediated by the Angiotensin II Type 1 Receptor
It has been shown that podocytes express two Angiotensin II receptors, AngII type
1 receptor (AT1R) and type 2 receptor (AT2R) [95]. To clarify which receptor
is responsible for mediating the observed calcium transients in podocytes in vivo
we aimed at pharmacological inhibition of both receptors. To verify the role of
AT1R, we imaged the same glomerulus before and after administration of losartan,
a clinically used AT1R blocker. Podocyte area reacting with a calcium signal
measured before and after administration of losartan is shown in Figure 18a. After
administration of losartan no signal could be induced by AngII infusion indicating
that losartan completely blocks AngII-mediated calcium transients. Representative
images of a glomerulus before and after treatment of losartan is shown in Figure
18b.
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Figure 18: Losartan, an inhibitor of the AT1R, completely inhibits AngII
mediated calcium signaling in vivo. a, Percentage of podocyte area reacting
with a calcium signal upon AngII (100 ng/g/min) before and after treatment with
Losartan (10 mg/kg). b, Representative images of the same glomerulus stimulated
with AngII before (top row) and after treatment with Losartan (bottom row). Green
channel is shown in false color code. student’s t-test: ***p=0007. Scale bar: 20 µm.
To understand the role of AT2R we administered PD123319, a compound
which has been shown to selectively and effectively inhibit signaling mediated by
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the AT2R [96]. Inhibition of AT2R had no consistent effect on AngII induced
calcium transients in podocytes. In some measurements the signal is decreased after
PD123319 while in other measurements the signal is further increased concluding
that PD123319 is not able to inhibit AngII-mediated calcium transients in podocytes.
The measured podocyte area showing a calcium signal in response to AngII infusion
before and after administration of PD123319 is shown in Figure 19a. Figure 19b
shows representative images of a glomerulus stimulated with AngII before and after
administration of PD123319.
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Figure 19: PD123319, an inhibitor of the AT2R, does not inhibit AngII-
mediated calcium transients in vivo. a, Percentage of podocyte area reacting
with a calcium signal upon AngII (100 ng/g/min) before and after treatment with
PD123319 (10 mg/kg). b, Representative images of the same glomerulus stimulated
with AngII before (top row) and after treatment with PD123319 (bottom row). Green
channel is shown in false color code. student’s t-test: p=0.9496. Scale bar: 20 µm.
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6.1.10 Characterization of the AngII mediated calcium signal
In a next step we aimed at characterizing possible differences between the AngII-
mediated calcium signaling measured in healthy and injured podocytes. Therefore
we measured single podocyte fluorescence dynamics in healthy controls and mice
pre-treated with Adriamycin. Figure 20 shows representative images of a glomerulus
of a control animal infused with AngII (100 ng/g/min) (Figure 20 a) and for ADR
treated animals (Figure 20 c). In the initial images (t=0s) two regions of interest
(ROIs) are defined. The relative fluorescence changes measured in these ROIs over
time are shown in b and d, respectively. In these measurements both animals were
infused the same dose of Angiotensin II (infusion time: 80 s). In the control animal
two podocytes showed a calcium signal while in the ADR treated animals almost
all podocytes in the plane of imaging showed a calcium signal. The relative change
in GCaMP3 fluorescence is comparable between both groups with a maximum
increase between three and four fold (Figure 20 b, d). Therefore we could not verify
a difference in the calcium increase between healthy and disease state on a single
podocyte level, if a calcium transient is triggered.
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Figure 20: Analysis relative GCaMP3 fluorescence over time in single
podocytes. a, Time lapse images of a glomerulus of a Pod:cre GCaMP3fl/fl (control)
animal during infusion of 100 ng/g/min AngII (depicted by a bar in (b)). Green
channel is shown in false color code. Two regions of interest (ROIs) (green and blue)
for single podocytes are defined in the first image. b, Relative changes in fluorescence
(Fmax/ FF0) in the ROIs shown in (a) are plotted over time. c, Time lapse images of
a glomerulus of a Pod:cre GCaMP3fl/fl animal pretreated with Adriamycin (ADR)
and stimulated with 100 ng/g/min AngII (depicted by a bar in(d)). Two regions of
interest (ROIs) (green and blue) for single podocytes are defined in the first image of
the time series. d, Relative changes in fluorescence (Fmax/F0) for the ROIs shown in
(c) are plotted over time. Scale bar: 20 µm.
Furthermore, we wanted to investigate if the AngII induced calcium signals differ
in duration of the signal in the different animal groups, specifically between healthy
and diseased animals (ADR treated and PodpKO animals) and whether loss of Trpc6
(Trpc6KO and Trpc6KO ADR) had an effect on the signal duration. Signal duration of
a single podocyte was defined by the time between the start of increased fluorescence
intensity during AngII infusion and the decrease of fluorescence intensity back
to its baseline level. The baseline level was defined as the measured fluorescence
intensity before AngII.
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Additionally, we compared our results to two published ways to trigger calcium
signals in podocytes. Podocyte injury by laser damage has been demonstrated
by Burford et al. [75]. The heat damage caused by the laser results in a calcium
increase around the burning site and triggers a calcium wave across the glomerulus.
And in 2016 Koehler et al. [97] showed that calcium transients can be induced in
podocytes expressing a designer receptor, which can be exclusively activated by
designer drug (DREADD). In this set up clozapine-N-oxide (CNO) was used as
stimulating compound.
Analysis of signal duration of single podocytes for animals stimulated with 100
ng/g/min and laser induced unjury showed a mean signal duration of 10 to 19
s, while DREADD + CNO stimulation showed a significant longer signal of 32
seconds (Figure 21 a). Furthermore, we analyzed the relative fluorescence increase
(Fmax/F0) in all groups. As shown in Figure 21b all groups showed an increase in
fluorescence between 3- to 4 fold. Taken together, the AngII treated groups show a
comparable increase in fluorescence intensity and signal duration, indicating that
podocytes respond with a uniform calcium transient if a certain threshold has been
passed and have a mechanism to quickly revert back to baseline.
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Figure 21: Characterization of Angiotensin-II induced calcium tran-
sients. a, Signal duration of calcium signals measured in single podocytes trig-
gered by stimulation with 100 ng/g/min AngII, laser induced damage and de-
signer drug-designer receptor (DREADD) interaction. Pod:cre GCaMP3fl/fl (control)
(mean=17±1 s, n=20), Pod:cre GCaMP3fl/fl Trpc6ko/ko (Trpc6KO) (mean=11±2.8
s, n=3), Pod:cre GCaMP3fl/fl treated with Adriamycin (ADR) (mean=15±0.7
s, n=81), Trpc6KO treated with Adriamycin (Trpc6KO ADR) (mean=13±0.6 s,
n=52), Pod:cre GCaMP3fl/fl Podocinfl/fl (PodppKO) (mean=15±1.1 s, n=41), Pod:cre
GCaMP3fl/fl Podocinfl/wt (PodppHet) (mean=19±1.2 s, n=35), laser injury in Pod:cre
GCaMP3fl/fl mice (mean=19±0.8 s, n=45) and a designer receptors exclusively acti-
vated by designer drug (DREADD+CNO) in Pod:cre GCaMP3fl/wt R26hM3Dtg/wt
mice (mean=32±2.8 s, n=16). b, Changes in relative GCaMP3 fluorescence
(Fmax/F0) are shown for the same groups as in (a). Control (mean=3.2±0.1, n=6,
m=17), Trpc6KO (mean=3.4±0.3, n=8, m=3), ADR (mean=3.4±0.1, n=39, m=9),
Trpc6KO ADR (mean=3.8±0.2, n=36, m=6), PodpKO (mean=3.7±0.2, n=32, m=5),
PodpHet (mean=3.7±0.2, n=28, m=7), laser injury (mean=3.8±0.3, n=20, m=4)
and DREADD (mean=3.2±0.3, n=16, m=3). n=number of podocytes analyzed,
m=number of mice. mean=SEM, One-way ANOVA Tukey’s multiple comparison
Test: #p<0.0001.
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6.1.11 Proteomic analysis of adriamycin treated mice
To understand the underlying mechanisms resulting in the observed increase in
responsiveness to AngII stimulation upon podocyte injury we performed quanti-
tative proteomic analysis to investigate dynamic changes of protein expression in
mice treated with ADR or NaCl (vehicle) at day 3 after treatment. To this end,
we isolated glomeruli as described in 5.2.10 and 5.2.12 from mice and performed
nLC-MS/MS. We identified a total of 3207 proteins and quantified 1847 of them
(see 5.2.12). Differential analysis as described in 5.3.4 demonstrated a signifi-
cantly increased expression of 127 proteins, whereas 150 proteins were decreased.
Among the increased proteins associated with calcium signaling were glutathione
S-transferase omega-1 (Gsto1), ankryin-3 (Ank3), citrin (solute carrier family 25
member 13, Slc25a13), Bax and demantin (Dmtn) (Figure 22). Table 14 lists the
top 10 of proteins upregulated in Adriamycin nephropathy and table 15 lists the
top 10 proteins down regulated compared to control. We were not able to detect
any angiotensin II receptor (AT1R and AT2R) or the Trpc6 channel.
Table 14: Top 10 of upregulated proteins in Adriamycin nephropathy
P-value Protein name Gene
name
5,494169681 Glutathione S-transferase omega-1 Gsto1
3,902950498 Pleckstrin homology-like domain family A mem-
ber 3
Phlda3
2,974969838 Cystatin-C Cst3
2,781908504 28S ribosomal protein S22, mitochondrial Mrps22
2,53533579 Plastin-1 Pls1
Continued on next page
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2,529581351 NADH dehydrogenase [ubiquinone] iron-sulfur
protein 7, mitochondrial
Ndufs7
2,473646713 NADH dehydrogenase [ubiquinone] iron-sulfur
protein 7, mitochondrial
Por
2,374697773 L-xylulose reductase Dcxr
2,207090917 NFU1 iron-sulfur cluster scaffold homolog, mito-
chondrial
Nfu1
2,195622915 Cathepsin-D Ctsd
Table 15: Top 10 of downregulated proteins in Adriamycin nephropathy
P-value Protein name Gene
name
3,108866222 Sorting nexin-27 Snx27
2,871112004 Ras-related protein Ral-B Ralb
2,737441072 Target of Myb protein 1 Tom1
2,591391439 Fryl
2,509630694 Protein BUD31 homolog Bud31
2,387389673 Importin subunit alpha-4 Kpna3
2,332024744 26S proteasome non-ATPase regulatory subunit
11
Psmd11
2,32021624 Serine/threonine-protein kinase PAK 1 Pak1
2,313692403 Phosphoribosylformylglycinamidine synthase Pfas
2,292647546 Engulfment and cell motility protein 2 Elmo2
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Figure 22: Quantitative proteomic analysis of protein expression of Adri-
amycin treated C57BL6 wildtype mice at day 3 after injection compared
to vehicle treated mice (d3). volcano-Blot representing the differentially regu-
lated proteins in control vs Adriamycin (ADR) treated animals (day 3). The negative
decadic logarithm of each protein is plotted against the log2 Difference (control (day
3)/ADR (day 3)) of each protein. Proteins beyond the line represent proteins largely
different between both samples (s0 = 1 and FDR >0.01). Proteins upregulated and
associated with calcium signaling are labeled in red and with their respective gene
symbol.
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6.2 Puringeric calcium signaling in glomerular cells
6.2.1 Expression of GCaMP3 in endothelial cells
Purinergic signaling, especially signaling mediated by adenosine-triphosphate (A-
TP), has shown to play a crucial role in regulating renal hemodynamics and is a
potent activator of calcium signaling in endothelial cells [98, 99]. In order to observe
calcium signaling in glomerular endothelial cells we crossed our GCaMP3fl/fl mice
to a Tie2:cre mouse line, which expresses Cre under an endothelial cell specific
promoter. Figure 23a shows the overall expression pattern of GCaMP3 in glomerular
endothelial cells. Fluorescence is visible in a thin cell layer enclosing the capillary
lumen (Figure 23 b). The vasculature was labelled by injection of 70 kDa Texas
Red.
mergea
b
GCaMP3 TexasRed
Figure 23: Expression of GCaMP3 in glomerular endothelial cells in vivo
a, Representative image of a glomerulus with endothelial cells expressing GCaMP3.
Vasculature was labelled by injection of 70 kDa dextrane Texas Red (magenta). b,
Higher zoom onto a part of a calpillary indicated by the dashed box in (a). Scale bar:
20 µm.
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6.2.2 Glomerular endothelial cells show a strong response to ATP in vivo
Stimulation of endothelial cells was accomplished by bolus injection of 0.5 µg
ATP. During bolus injection a minor part of the administered dose remains in the
catheter, therefore a manual flush of the catheter is necessary to ensure that the
entire dose is administered. Due to handling there is always a short pause between
bolus injection and flushing of the catheter.
Upon injection of ATP endothelial cells showed a strong calcium signal in all
glomerular cells expressing GCaMP3 (Figure 24 a). Bolus injection was carried
out at t=10s (not shown) and the calcium signal was recorded ∼ 3s later (t=13s).
Interestingly, the endothelial cells of the efferent arteriole, indicated by dashed lines,
also showed a calcium signal. The efferent arteriole was localized by comparing
the Z-Stack acquired before administration of ATP with the time series acquired
during ATP injection. The signal shown here lasted approximately 4 to 5 seconds.
Analysis of changes in the relative fluorescence of GCaMP3 in single endothelial
cells, marked in (a) at t=0s, shows a 3 to 4 fold increase in relative fluorescence
(Figure 24 b). The relative fluorescence increase of the total glomerular area (black
line trace) is less, which is accounted for by additionally averaging areas in the
glomerulus not expressing GCaMP3 like the capillary lumen. We conclude, that
ATP is a potent activator of calcium signaling in glomerular endothelial cells.
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Figure 24: ATP induces a strong calcium signal in glomerular endothelial
cells in vivo. a, Representative images of a glomerulus expressing GCaMP3 in
endothelial cells injected with 0.5 µg ATP. Green channel is shown in false color
code. t=0 s shows the glomerulus before injection of ATP, t=13 s shows the calcium
signal immediately after injection (t=10 s, no shown), t=20 s calcium levels back at
baseline. In the first image (t=0 s) three cells are marked, corresponding to b. b,
Relative fluorescence changes for three single cells marked in a (first image) and the
entire glomerulus. Arrow indicates time point of injection. Scale bar: 40 µm.
Upon increasing the ATP dose by 10-fold to 5 µg we were able to stimulate the
peritubular capillary bed, as post-glomerular endothelial cells showed a calcium
signal as indicated by the arrow heads and asterisks (*) (Figure 25). This indicates
that ATP is not completely consumed by binding to its receptors or is degraded by
enzymes called ectonucleotidases which can be found in the entire nephron [70].
Meaning, that a sufficient amount of the injected ATP reaches the glomerulus
and capillaries downstream of the glomerular capillary bed. Taken together,
endothelial cells show a strong calcium response to ATP and to target endothelial
cells downstream of the glomerulus higher doses are necessary.
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Figure 25: High doses of ATP reaches endothelial cells downstream of the
glomerulus. Representative images of a mouse expressing GCaMP3 in endothelial
cells injected with 5 µg ATP. Green channel is shown in false color code. t=0 s shows
the glomerulus before injection of ATP. t=13 s shows the calcium signal immediately
after injection (t=10 s, not shown). Arrow heads indicate peritubular endothelial
cells showing a calcium signal together with the glomerular endothelial cells. t=14 s
shows that more distant endothelial cells (*, asteriskses) now are stimulated by ATP
and react with a calcium signal. t=30 s , the calcium level is back at baseline. Scale
bar: 40 µm.
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6.2.3 ATP-mediated calcium transients can be blocked by high-dose Suramin
In a next step we administered Suramin, an unspecific purinergic receptor inhibitor
to block the ATP-mediated calcium signals. In order to achieve complete inhibition
we injected a total dose of 2.5 mg. At lower doses Suramin was not potent to
achieve inhibition (not shown). Representative images show the same glomerulus
stimulated with 0.5 µg ATP before and after administration of Suramin (Figure
26 a, b). One can notice that in b the injection of ATP induced a strong shift
which resulted in an increase in fluorescence. This increase is also represented
in the graph (Figure 26 c) and correlates with the time point of ATP injection
(grey arrow). The observed shift is due to the endogenous function of ATP on
vascular hemodynamics resulting in vasoconstriction. Concluding, that blocking
of purinergic receptors is possible but requires high doses and that the observed
signal is based on the direct effect of ATP binding to its receptor and not by a
heamodynamic effect on endothelial cells.
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Figure 26: High dose of Suramin completely inhibits ATP-mediated cal-
cium signals in endothelial cells. a, b, Representative images of a glomerulus
expressing GCaMP3 in endothelial cells injected with 0.5 µg ATP before (a) and after
(b) adminstration of Suramin (2.5 mg). t=0 s shows the glomerulus before injection
of ATP, t=27 s shows the glomerulus shortly after administration of ATP and t=40
s shows the glomerulus with the fluorescence back at baseline. Baseline is defined
as the fluorescence intensity before administration of ATP. Green channel is shown
in false color code. c, Relative changes in GCaMP3 fluorescence over time upon
injection of 0.5 µg ATP. The red arrow indicates the time point of ATP injection
before administration of Suramin, and the grey arrow indicated the time point of
ATP injection after administration of Suramin. Scale bar: 40 µm.
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6.2.4 Proximal tubular cells respond with a calcium signal upon stimulation with ATP
To this point, we were able to show that ATP induces dose-dependent calcium
transients in endothelial cells which can be blocked by inhibition of ATP receptors.
Since it has been shown that enzymes, termed ectonucleotidases, capable to degrade
ATP to adenosine diphosphate (ADP), are present in the glomerulus [70] we wanted
to investigate if ATP is filtered into the primary ultrafiltrate and could therefore
directly act on podocytes in vivo. To clarify this question we set out to investigate
the calcium response to ATP in proximal tubular cells. To be able to monitor
calcium transients in proximal tubular cells we crossed GCaMP3fl/fl with Pax8:cre
mice to achieve GCaMP3 expression. Pax8:cre shows expression in the entire
nephron, whereby the expression is higher in proximal and distal tubular cells
compared to podocytes as shown in Figure 27. Again the vasculature was labelled
by injection of 70 kDa Texas Red. The left panel shows the expression of GCaMP3
mainly in proximal cells with a pronounced apical localization but also in a distal
tubule indicated by the dashed lines (right panel) and in podocytes.
GCaMP3 Texas Red merge
Figure 27: Expression of GCaMP3 in proximal tubular cells Left: GCaMP3
expression in proximal and distal tubular segments and in podocytes. Arrow head
indicates a cell of a distal tubular segment with an increased calcium level. Middle:
Red channel, fluorescence of 70 kDa Texas Red labelling the vasculature. Right:
merged channels. Dashed line indicates a distal tubular segment. Scale bar: 40 µm.
Interestingly, tubular cells show spontaneous intracellular calcium oscillations
represented by changing levels of GCaMP3 fluorescence as shown in Figure 28.
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The images depicts the same tubular region within a time frame of 60 seconds
without any intervention during this time. Arrowheads indicate cells with increased
GCaMP3 fluorescence. This observation has been also made been made previously
using transgenic rats [100].
Figure 28: Tubular cells show spontaneous calcium oscillations at baseline
Green channel is shown in grey. Arrowheads point to cells with increased GCaMP3
fluorescence. Scale bar: 40 µm.
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6.2.5 Proximal tubular cells show a strong response to ATP
To verify if the injected dose of ATP is filtered and thus present in Bowman’s
space where it could potentially bind to ATP receptors expressed by podocytes
we injected mice expressing GCaMP3 in tubular cells with 1 µg ATP (Figure 27).
Figure 29 shows the calcium transients induced by ATP in proximal tubular cells.
For clarification t=0s, i) shows the imaged region with the GCaMP3 fluorescence
shown in green and Texas Red shown in red with the glomerulus indicated by the
dashed line. Image t=0s, ii) and subsequent images only show the green channel in
false color code. t=25s shows the area just after injection of ATP. Within a few
seconds a bright GCaMP3 signal can be observed, reflective of high intracellular
calcium levels. The signal increases further over time with its maximum at t=35s
where almost all tubular segments show a strong calcium signal. At t=50s the
signal is approximately back at baseline (t=0s). Taken together, 1 µg was sufficient
to induce a strong signal in proximal tubular segments but no signal could be
detected in podocytes. The observed calcium transients in proximal tubular cells
could be possible induced by either stimulation through the peritubular capillary
system or by ATP being present in the primary ultrafiltrate.
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Figure 29: Tubular cells show a strong calcium signal upon injection of
ATP. Representative images of a glomerulus and tubular region during injection of 1
µg ATP. t=0 s, i) show the GCaMP3 fluorescence in green and Texas Red fluorescence
in magenta. Dashed line indicates the glomerulus. Image t=0 s, ii) and subsequent
images shows the GCaMP3 fluorescence only in false color code, the red channel
(magenta) is not shown. Image t=0 s shows the region before injection of ATP. t=25
s show the region immediately after injection of ATP. Scale bar: 40 µm.
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6.2.6 Calcium wave in podocytes induced by laser injury
To this point, we have shown that endothelial and proximal tubular cells can
be stimulated by ATP resulting in intracellular calcium transients. Furthermore,
purinergic signaling has been shown to induce calcium transients in podocyte cell
culture experiments and using isolated glomeruli. Also, Burford et al. (2014) have
shown that purinergic signaling could play a role in mediating calcium transients
in podocytes using intravital microscopy [75]. In their publication they induced
elevated calcium levels in podocytes by causing a laser-induced injury. To achieve
this, the laser is focused on one podocyte in a glomerulus which leads to a heat
damage at that point due to high laser power focused on a small area (see 5.2.8).
We recapitulated their findings using our in vivo imaging settings. Figure 30a
depicts how the calcium wave spreads from the point of injury (marked by an X) to
podocytes further away. At t=1s a calcium signal can be observed directly adjacent
to the injury site (Fig. 30 a, red circle). In this region the fluorescence decreases
over time but does not go back to the baseline level, indicating sustained podocyte
damage [75]. This is in contrast to the other podocytes showing a calcium signal.
Here, the intracellular calcium levels rises and goes back to baseline levels (Figure
30 b). The spreading of the calcium signal has been termed "calcium wave" [75].
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Figure 30: Calcium wave in podocytes triggered by laser induced injury
in vivo. a, Representative images of a glomerulus over time (t=0 s to t=90 s) after
laser induced injury. In t=0 s the yellow X marks the point of injury. The colored
circles define different regions of interest (ROIs) in which the fluorescent changes over
time were analyzed (b). b, Relative fluorescence changes (Fmax/F0) of the calcium
indicator GCaMP3 over time for the ROIs indicated in (a). Green channel is shown
in false color code. Scale bar: 40 µm.
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6.2.7 ATP plays a role in propagating calcium transients observed upon laser injury
Since Burford et al. used ATP receptor inhibitors to identify ATP as a mediator of
the observed calcium wave we wanted to confirm this finding. Therefore we used
Suramin, a broad spectrum antagonist of purinergic receptors (P2X and P2Y), to
block ATP-mediated calcium signaling [75]. Additionally, we used Lanthanumchlo-
ride (LaCl3), an inhibitor of the transient receptor potential channel 6 (Trpc6),
to inhibit calcium influx from the extracellular space. The number of glomeruli
showing a calcium wave upon laser-induced injury, depicted as percentage, does not
differ in control mice treated with NaCl (vehicle), Suramin or LaCl3 as shown in Fig-
ure 31a. Furthermore, we measured the relative fluorescence increase of GCaMP3
in single podocytes and the number of podocytes showing a calcium signal in the
different groups. No difference in the relative fluorescence (Fmax/F0) of GCaMP3
in single podocytes and in the number of podocytes showing a calcium signal
could be detected (Figure31 b, c). However, measurement of the time between the
laser-induced injury and the start of the calcium wave, meaning the first podocyte
showing a calcium signal after injury, is significantly different between the groups.
In control mice (vehicle) the mean time was 19 s, which increased by two-fold to
a mean of 41 s in Suramin and to 51 s in LaCl3 treated animals (Figure 31 d).
Consequently, purinergic receptors could play a role in signal transmission between
podocytes. Furthermore, even though LaCl3 was able to delay the propagation
of the calcium wave, it did not inhibit it completely suggesting that either more
calcium permeable channels are involved or intracellular calcium stores are opened.
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Figure 31: Inhibition of calcium influx and ATP receptors delays a calcium
wave spreading over the glomeruli. a, percentage of glomeruli showing a calcium
signal upon laser-induced injury in animals treated with NaCl (control, n=27),
Suramin (1 mg, n=23) or LaCl3 (check dosis, n=13). n=number of glomeruli analyzed.
b, Changes in the relative fluorescence (Fmax/F0). NaCl (n=67, mean=4.8±0.2),
Suramin (n=72, mean=5.1±0.2) and LaCl3 (n=42, mean=4.5±0.2). c, Number
of podocytes showing a calcium signal upon laser-induced injury. NaCl (n=17,
mean=7.8±0.9), Suramin (n=18, mean=7.2±0.9), LaCl3 (n=10, mean=7.7±1.2). d,
Analysis of the time between injury initiation and the start of the calcium wave. NaCl
(n=14, mean=18.8±2.7 s), Suramin (n=19, mean=40.6±7.4 s) and LaCl3 (n=10,
mean=50.5±8.1 s). n=number of podocytes analyzed. mean=SEM, #p=0.0115
One-way ANOVA Tukey’s multiple comparison Test.
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6.2.8 ATP is not able to trigger a calcium signal in podocytes in vivo
Since ATP seems to be involved in signaling between podocytes upon laser-induced
injury we aimed at inducing calcium signals by directly stimulating purinergic
receptors with ATP as shown for endothelial and proximal tubular cells (0.5 to 1
µg ATP). To this end we administered doses between 2 and 10 µg of ATP as bolus
injections and flushed the catheter afterwards. Unfortunately, we were not able to
trigger any calcium signal in healthy podocytes at any dose, instead injection of
ATP resulted in strong effects on the blood flow by causing vasoconstriction [67].
Figure 32 shows representative images of a glomerulus of a mouse injected with
2 µg ATP and its effects on glomerular hemodynamics but no calcium signal can
be observed. The white dashed line indicates a capillary region before (t=0s) and
just after (t=15s) injection of ATP. At t=0s the capillary shows normal blood flow,
indicated by the black lines caused by blood cells passing through the capillary.
Due to their high velocity and lack of fluorescence the cells appear as black lines.
At t=15s the black lines in the same capillary region are absent, instead the round
shape of blood cells is visible indicating a severe decrease of blood flow. It should
be noted that the blood flow normalizes quickly after the initial injection (t=20s).
Furthermore, the injection of ATP results in unstable image acquisition. This
change becomes obvious when comparing the glomerular size indicated by the grey
dashed line at t=0s, t=25s and t=50s. The grey dashed line highlights the edges
of the glomerulus at t=0s (before injection) in this particular image plane. The
glomerular area is smaller at t=25s and t=50s since the glomerulus shifted upwards
or downwards, respectively, resulting in a smaller portion of the glomerulus to be
visible. At t=25s GCaMP3 fluorescence in podocytes seems to be increased but
it should not be interpreted as a calcium signal since the fluorescence intensity is
the same in the Z-Stack (not shown) acquired prior to injection. Taken together,
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injection of ATP produced strong physiological effects on blood flow resulting in
unstable imaging acquisition but no detectable calcium signaling in podocytes.
t=0s t=15s t=20s 2 μg ATP bolus
t=25s t=30s t=40s
t=50s t=60s t=90s
flush
Figure 32: Bolus injection of ATP does not result in a calcium signal in
podocytes but has a strong effects on blood flow. Representative images of
a glomerulus of a healthy animal injected with ATP. A bolus of ATP (2 µg) was
injected just before t=15 s. The dashed white line in the first image (t=0 s) and
the second (t=15 s) mark the same capillary regions. The grey dashed line in t=0
s, t=25 s and t=50 s represent the size of the glomerulus at t=0 s and its changes
during the course of imaging. At t=25 s the line was flushed, resulting in a second
application of ATP. Scale bar: 40 µm.
Considering the fact that ATP is rapidly degraded or consumed we used a
non-hydrolyzed ATP analogue called ATP-γ-S. We administered doses between 1
and 2 µg with no effect on calcium levels in podocytes but with comparable effects
on the animal’s physiology (not shown). Furthermore, repetitive bolus injections of
ATP or ATP-γ-S resulted in complete loss of blood flow in the entire kidney and
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ultimately in death of the animal. Table 16 gives and overview of the number of
experiments performed using ATP or ATP-γ-S and the respective doses. In total
a number of 30 mice and 56 individual glomeruli were imaged. Taken together
ATP, or its non-hydrolyzable analogue were not able to induce calcium transients
in podocytes while lower doses of 0.5 µg and 1 µg of ATP was sufficient to induce
calcium signaling in endothelial and proximal tubular cells.
Table 16: Overview of ATP experiments in vivo
Substance Dose Number of glomeruli
ATP 1µg 6
ATP 2µg 56
ATP >2µg 9
ATPγ–S 2µg 11
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6.2.9 ATP mediates calcium transients in isolated glomeruli
Considering the fact that we were not able to induce calcium signaling in podocytes
in vivo by injecting ATP we decided to isolate glomeruli from mouse kidneys and
stimulate these with ATP. As discussed before, we could not use our transgenic
mice expressing GCaMP3 selectively in podocytes (Pod:cre GCaMP3fl/fl) due to
instability of the calcium indicator. Therefore we isolated glomeruli from C57Bl6
mice and loaded them with Fluo4 for calcium imaging. Similar experiments using
isolated glomeruli from rat have already been performed by Ilatovskaya et al. (2013)
[73]. Representative images of a glomerulus are shown in Figure 33a. When we
superfused the isolated glomeruli with solutions containing either 50, 100 or 200
µM ATP we were able to induce a strong and transient calcium signal as shown by
the relative fluorescence increase of Fluo4 over time, thereby 200 µM ATP induced
the most pronounced signal (Figure 33 b).
Figure 33: ATP induces dose dependent calcium transients in isolated
glomeruli. a, Representative images of a glomerulus loaded with Fluo4 (5 µM) and
stimulated with 200 µM ATP using a perfusion system (1 ml/min). Arrow heads
indicate cell showing increased calcium levels. The green channel is shown in false
color code. b, Relative fluorescence changes (FMax/ F0) over time for 50 µM ATP
(n=2), 100 µM ATP (n=13) and 200 µM ATP (n=48). Black bar indicates the time
period of ATP infusion. n=number of cells analyzed, mean=SEM, scale bar: 20 µm.
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Taken together, we were able to show a strong and reproducible dose dependent
calcium signals upon stimulation with ATP in cells which we identified as podocytes
by their structure and position in the ex vivo setting.
85
7 DISCUSSION
7 Discussion
7.1 AngII signaling and calcium are involved in podocyte injury
In the present study we set out to understand the role of Angiotensin II (AngII)
mediated calcium signaling in podocytes. AngII is a small peptide hormone
playing an important role in electrolyte homeostasis and blood pressure regulation.
Measurements of physiological AngII concentrations has revealed an increase in
AngII concentration (340 fmol/g) as compared to plasma concentrations (50 fmol/g).
However, its concentration in the glomerulus is not known, as studies mainly focus
on intratubular fluid concentrations and local AngII metabolism can alters its
concentration rapidly [101]. In the kidney, AngII regulates glomerular perfusion
pressure on a single nephron level. Excessive activation of the Renin-Angiotensin-
Aldosterone-Sytem (RAAS) is associated with disease and numerous studies using
cell culture models, isolated glomeruli and in vivo models using transgenic animals
have shown a connection between over-activation of this pathway and disease
initiation and progression. Furthermore, studies in patients show beneficial effects
of RAAS inhibition beyond blood pressure control for renal outcome in patients
with proteinuria [102, 103]. AngII receptors (ATRs) belong to the family of G-
protein coupled receptors (GPCRs) which are able to activate transient receptor
potential cation channel (Trpc6). Activation of Trpc6 in a dysregulated manner
has been shown to cause kidney disease in humans [16]. We wanted to understand
the connection between AngII signaling and elevated calcium levels in the in vivo
setting. To this end we applied intravital imaging of healthy and diseased animals
expressing the calcium indicator GCaMP3 selectively in podocytes.
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7.1.1 Podocytes maintain low intracellular calcium levels
At baseline, podocytes did not show any spontaneous calcium signals but a stable
GCaMP3 fluorescence. Furthermore, we measured the GCaMP3 fluorescence over
time and did not oberserve effects of bleaching in our imaging settings. The low
baseline fluorescence observed in podocytes in vivo has previously been described
[75]. The importance of low intracellular calcium levels is even more emphasized
by the observation that, AngII mediated calcium transients in healthy and injured
podocytes drop back to baseline within a few seconds represented by a fast decrease
in GCaMP3 fluorescence. The same holds true for a laser-induced calcium wave.
Therefore it can be concluded that regulation of intracellular calcium levels is
crucial for podocytes. Nevertheless, one should keep in mind that this animal
model includes overexpression of a calmodulin based calcium sensor. Calmodulin
is an ubiquitously expressed calcium binding molecule and therefore it can not be
excluded that its expression may interfere with calcium and calmodulin signaling
[104]. Nevertheless, GCaMP3 has been successfully used in previous studies to
monitor action potentials in mouse brain thereby proving its sensitivity and fast
signaling [105].
7.1.2 Healthy podocytes show a low responsiveness to AngII
Using in vivo stimulation with a dose of 100 ng/g/min AngII we could induce
calcium signaling in a minor fraction of healthy podocytes. The observed low
responsiveness of healthy podocytes to AngII stimulation is in contrast to published
data using podocyte cell culture, isolated glomeruli loaded with calcium sensitive
dyes and patch-clamp experiments. In these experiments robust calcium transients
could be observed and depolarization of podocyte cell membrane upon AngII
stimulation was measured [93, 56, 95, 57]. Our effort to use isolated glomeruli
of mice expressing GCaMP3 failed since the fluorescence signal was completely
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diminished after isolation. Loading of isolated glomeruli with Fluo4 was successful
but we could not observe calcium signals in a reproducible manner as published by
others [59]. Furthermore, after isolation a lot of cells per glomerulus stained positive
with propidium iodide (PI), indicating a high degree of cell death. In contrast,
in healthy control mice no uptake of PI could be observed in any glomerular cell
during in vivo imaging. While, proximal tubular cells showed a time-dependent
unspecific uptake within 30 to 60 minutes.
Based on our observations using isolated glomeruli and our results we obtained
from intravital microscopy of AngII-mediated calcium transients in podocytes we
concluded that ex vivo and in vitro models have severe shortcomings in modeling the
in vivo situation. On the one hand, glomerular isolation protocols result in damage
to the glomerular integrity as indicated by PI positive nuclei. In our approach we
used a short collagenase digestion and gentle purification and minimized mechanical
strain on the tissue. In contrast, isolation of glomeruli from rats uses sequential
sieving steps thereby applying more physical pressure on the tissue which likely
causes more damage.
On the other hand, cell culture models cannot recapitulate the complex ar-
chitecture of a glomerulus consisting of different cell types and its subjection to
capillary and filtration pressure. The aforementioned limitations of ex vivo models
might explain the contradiction of their results to the in vivo situation of the
low responsiveness of podocytes to AngII stimulation. Minimal changes in cell
membrane depolarization could be missed by our approach. Additionally, use of
isolated glomeruli represents a state of damage to the glomeruli, which we do not
observe in healthy animals.
88
7 DISCUSSION
7.1.3 Podocyte injury increases AngII-mediated calcium signals in vivo
To further elucidate the role of AngII-mediated calcium transients in disease we
applied two different disease models both based on podocyte injury. Considering
the fact that we need relatively young mice of age (3 to 4 weeks) for intravital
imaging of glomeruli we chose an acute chemically induced podocyte injury model
and a genetic model with an early onset. Chemically induced podocyte injury
was achieved by injection of 25 mg/kg of Adriamycin (ADR) in Pod:Cre GCaMP3
mice in C57Bl6 background. Adriamycin is a chemotherapeutic agent and is a
well-established model for focal segmental glomerulusclerosis (FSGS) in mice [106].
In this model, a single dose of the agent is sufficient to induce weight loss (not
shown), proteinuria and histological abnormalities in 4 week old mice within five
days after injection. As a second disease model we chose a genetic model, where the
slit diaphgram component podocin is specifically deleted in podocytes. Mice with a
homozygous deletion of podocin developed severe proteinuria and glomerulusclerosis
by the age of 4 weeks [107].
We subjected mice of both models to in vivo imaging and AngII stimulation to
monitor calcium levels. Without intervention injured podocytes did not show any
spontaneous calcium signals, however in both models, but predominantly in the
podocin knockout model (PodpKO) single podocytes showed an increase GCaMP3
fluorescence compared to neighboring cells. This could be reflective of injury as
cells could have lost their ability to maintain a stable low intracellular calcium
concentration as observed during laser-induced injury at the site of heat damage
[75].
When ADR or PodpKO animals were subjected to acute AngII infusion we could
measure an ∼2- to 3-fold increase in the AngII responsiveness in both models
represented by the number of glomeruli showing a calcium signal in at least one
podocyte. From this we concluded that injury rendered podocytes sensitive to
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AngII-mediated calcium signals. Since podocyte specific overexpression of AngII
type 1 receptor (AT1R) has been shown to be sufficient to induce proteinuria and
FSGS lesions [108] we hypothesize that AngII signaling could aggravate a already
present podocyte injury. This in turn could explain why patients suffering from
proteinuric kidney disease profit the most from RAAS inhibition in regard to kidney
function [102, 103].
7.1.4 Heterozygous loss of podocin effects AngII signaling in podocytes
As a control for PodpKO animals we used mice with loss of one allele of podocin
(PodpHet) in our experimental set up. These mice were healthy and did not show
any proteinuria or histological changes in kidney biopsies. Interestingly, PodpHet
mice also showed an increased responsiveness to AngII compared to healthy control
animals. Currently we can only hypothesize that loss of one podocin allele rendered
cells more susceptible to AngII than control mice. Therefore, podocin might have
gene-dose dependent functions. Since podocin is highly expressed in podocytes,
loss of one allele might reduce the amount of protein at the slit diaphragm to a
degree which makes it susceptible to AngII-mediated signaling. To answer this
question PodpHet mice could be subjected to stress models such as Adriamycin,
continuous low dose AngII infusion with osmotic mini pumps or a hypertension
model.
7.1.5 Loss of Trpc6 does not block AngII-mediated calcium transients
The cation channel Trpc6 has been implicated to play a crucial role in podocyte
calcium handling and there is experimental evidence that signaling via AngII
receptors is able to acitivate Trpc6 channels [109, 57]. Therefore, we used a Trpc6
whole body knock out mouse model (Trpc6KO) to verify if we lose AngII-mediated
calcium signaling [82]. Our experiments show that AngII can still induce calcium
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signaling in Trpc6 deficient podocytes in healthy and disease state, but to a lesser
extent than in control mice. Given that we use a whole-body knock out mouse
model it might very well be that other cation channels compensate for the loss
of Trpc6, one candidate could be Trpc5. Trpc5 belongs to same family of cation
channels even though its role as a protective or harmful agent in context of kidney
injury remains a matter of debate [110, 111]. To verify if and which other calcium
conductive channels are involved in AngII calcium signaling one could use channel
specific inhibitors or a genetic approach by deleting Trpc5.
7.1.6 A common mechanism of podocytes in handling increased calcium levels
Further analysis of AngII-mediated calcium signaling showed that signal duration
on a single podocyte level was the same in all groups treated with AngII and there
was no difference between healthy and injured cells. Additionally we compared
the relative fluorescence increases (Fmax/ F0) between all groups and could not
find a significant difference. From this we concluded that the observed signal is an
all-or-nothing response. This could be based on intrinsic molecular properties of the
calcium indicator GCaMP3 which define its maximum intensity [105]. Molecular
aspects also include the route of calcium entry into the cell, like activation of cell
membrane cation channels by G-protein couples receptors (GPCRs) and calcium
release from the endoplasmatic reticulum (ER). AngII receptors belong to the
class of GPCRs. Activation of GPCRs results in generation of diacylglyerol (DAG)
and inositol-1,4,5-triphosphate (IP3) which can activate cation channels by DAG
in the cell membrane and IP3 regulated calcium channels on the ER membrane.
Opening of any calcium channel will result in calcium entry along its concentration
gradient. We hypothesize that during this signaling cascade a threshold is exceeded,
opening further cation channels and thereby triggering the maximum fluorescence
of GCaMP3. Small local elevations of calcium levels which do not activate release of
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calcium from the ER might therefore not be represented in our measurements, since
GCaMP3 is expressed in the cytosol and not specifically targeted to the cytoplasmic
membrane. Visualization of calcium signaling at the membrane, especially in the
foot processes, could be achieved by targeting GCaMP3 to the membrane.
7.1.7 Direct or indirect effects of AngII on calcium levels in podocytes
For podocytes it has been proposed that mechanical strain effects intracellular
calcium levels [33, 79]. Considering the fact that the physiological function of AngII
is regulation of glomerular perfusion pressure by inducing vasoconstriction of the
efferent arteriole and subsequent swelling of the capillary loops can be observed,
therefore AngII signaling involves a mechanical stimulus. We cannot exclude this
mechanical component as an indirect effect on calcium levels in podocytes from
our current hypothesis. However, using Angiotensin II receptor (ATRs) inhibitors
we could show, that Angiotensin II type 1 receptor (AT1R) is responsible for the
observed calcium transients in podocytes upon AngII stimulation. Application of
Losartan completely inhibited AngII-mediated calcium signal. Losartan is a specific
AT1 receptor blocker which is widely used in clinics to lower blood pressure and
manage kidney disease [102]. In contrast, use of PD123319 which is a specific AT2
receptor blocker, did not show any consistent effect. These observations go well in
hand with published data [93, 95, 96]. Since our model only allows global inhibition
of ATRs we cannot distinguish between direct effects of AngII on podocytes or
other cell types. In order to solve this question we would need to use a genetic
approach by using cell specific AT1R knockout animals. Thereby we could delete
AT1R specifically from podocytes and endothelial cells and demonstrate cell-specific
effects which are responsible for the observed glomerular heamodynamic effects.
Podocyte specific AT1R knockout animals should still show a vasoactive response
to AngII, which should be lost in endothelial specific knockout. Thereby we could
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distinguish between indirect heamodynamic and direct non-heamodynamic effects.
Still, one should keep in mind that mice harbour two subtypes of the AT1 receptor
encoded by two different genes [42]. Current research is not clear on which subtype
is more relevant in the context of podocyte biology. Since there are no subtype
specific inhibitors available, a genetic approach with deletion of either AT1A or AT1B
is required to understand which receptor subtype is responsible for the observed
calcium transients in podocytes.
7.1.8 Proteomic analysis identifies calcium related proteins upregulated in ADR
Finally, we conducted proteomic analysis of ADR treated glomeruli to understand
changes in the proteome associated with the observed increased responsiveness
to AngII. Unfortunately, we were not able to identify any AngII receptor or the
Trpc6 channel in our dataset due to their low abundance abundance as previously
published [112]. However, we could identify calcium-associated proteins upregulated
in ADR treated groups compared to control, their function in AngII mediated
calcium signaling is not understood. Furthermore, the data shows a significant down
regulation of podocyte specific proteins such as podocin and neprhin indicating that
the disease model is functional and that the slit diaphragm structure is destabilized
during Adriamycin nephropathy. Nevertheless, one should keep in mind that our
proteomics data was generated using whole glom lysates. Therefore, measurement
of significantly upregulated proteins could be due to other cell types within the
glomerulus. Thus, proteomic analysis of single podocytes after ADR would provide
an even stronger data set. Additionally, validation of identified proteins and
their localization within the glomerulus could be verified by performing immune
fluorescence stainings.
The protein with the highest abundance found in ADR treated compared to
control glomeruli was the gluthathione S-transerase omega 1 (Gsto1). Gsto1 has
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been associated with stress responses, such as reactive oxygen species, and drug
metabolism. Hence, the observed upregulation is mostly likely directly induced by
Adriamycin treatment [113].
7.2 Podocytes show no response to ATP stimulation in vivo
In the present study we have used three different mouse models expressing GCa-
MP3 in either endothelial cells, proximal tubular cells or podocytes to delineate
differences in adenosine-triphosphate (ATP) mediated calcium transients in different
cell types of the nephron. We could show that endothelial cells and proximal tubular
cells show a strong and immediate response to stimulation with ATP, while this
response is absent in podocytes in vivo with the same dose.
7.2.1 Podocytes show a dose-dependent ATP response ex vivo
For podocyte cell culture it has been shown that podoctyes can release ATP upon
mechanical strain which could then act in an autocrine and paracrine manner
and activate purinergic receptors resulting in cation transients. Local increases of
cytosolic calcium levels effects the elaborate cytoskeleton of podocytes [35]. The
interplay between calcium and actin organization has been shown to be a common
mechanism in many different cell types [24]. Since calcium channels are found in
foot processes of podocytes, influx of calcium could directly alter the cytoskeleton
which is crucial for podocyte structure and function. Thereby, ATP signaling could
have a direct detrimental effect on filtration barrier function, if circulating ATP
which is filtered reaches podocytes.
Patch-clamp experiments on podocytes of isolated glomeruli and use of podo-
cyte cell culture have shown that podocytes are depolarized by ATP and increases
in intracellular calcium levels can be observed [55, 74, 66]. We and others could
show, using isolated glomeruli loaded with calcium sensitive dyes, that podocytes
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show a strong calcium response to ATP ex vivo. In our experiments, we identified
podocytes loaded with Fluo4 based on their localization within the glomerular
structure and morphology as we could not use glomeruli isolated from our transgenic
mouse model due to unstable fluorescence of GCaMP3 after isolation. In our ex vivo
experiments we applied different ATP doses ranging from 50 to 200 µM ATP and
measured transient calcium signals in a dose-dependent manner. Our findings go
well in hand with published data using glomeruli isolated from rats and stimulated
with 10 µM ATP [73]. Data obtained from cultured endothelial cells indicate that
20 µM ATP is sufficient to induce calcium transients [114].
7.2.2 Laser-induced injury and calcium signaling in podocytes involves ATP as a
messenger of injury
In vivo imaging studies in mice indicate that ATP signaling is involved in propa-
gation of a calcium wave upon laser-induced podocyte injury [75], which spreads
between neighboring podo-cytes. We could recapitulate these findings by inducing
the same podocyte injury. Furthermore, as published, we could interfere with signal
transmission by using the unspecific ATP receptor inhibitor suramin. Application
of suramin delayed the signal propagation, similar to what has been described
[75] but did not block it completely. Therefore, unknown factors are additionally
released into Bowman’s space upon laser-induced injury and play a role in the
observed calcium wave together with ATP. To address, which additionally factors
play a role in propagation of the calcium wave one could use different receptor
inhibitors to block other purinergic receptors specific to adenosine-diphosphate
(ADP) for example. Even though the model of laser-induced injury is a rather
artifical model for podocyte injury, but underlines the role of ATP signaling in
podocyte biology to spread a damage signal in vivo.
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7.2.3 Podocytes do not show a calcium signal upon ATP stimulation in vivo
In order to understand the role of ATP-mediated calcium transients in podocyte
biology we injected different doses of ATP into mice expressing GCaMP3 in podo-
cytes and monitored calcium transients. To this end, we used ATP doses between
1 to 10 µg of ATP but could not detect any ATP-mediated calcium transients in
podocytes. Since ATP is very quickly degraded by so-called ectonucleosidases or
consumed by cells we wanted to control if the injected doses actually reached the
glomeruli in the kidney. Therefore, we generated mice with expression of GCaMP3
under the endothelial cell specific promoter Tie2. Endothelial cells have been shown
to react to ATP with an intracellular calcium transient [99]. Upon stimulation of
Tie2: GCaMP3 mice with ATP (0.5 µg) we could observe a pronounced and fast
calcium signal in all glomerular endothelial cells including endothelial cells lining
the afferent arteriole. Furthermore, we could show that injection of higher doses of
ATP (2 µg) resulted in a calcium signal in post-glomerular endothelial cells. We
concluded, that the injected dose is sufficient to potentially reach glomeruli.
Since the glomerular basement membrane (GBM) is located between a layer
of endothelial cells and podocytes we wanted to confirm whether the injected
ATP is actually filtered and is therefore present in the Bowman’s space where it
could activate receptors on podocytes cell membrane. Therefore, we generated a
transgenic mouse line expressing GCaMP3 in proximal tubulur cells (Pax:cre). We
could observe that injection of 1 µg ATP was sufficient to induce a calcium signal in
proximal tubular cells indicating filtration of ATP. A similar experiment has been
conducted in transgenic rats expressing GCaMP2 in proximal tubular cells [100].
Still, one should keep in mind that proximal tubular cells are also connected to
pertibular capillaries on their basolateral site where they express ATP receptors as
well as on the luminal site [98, 115, 116]. Therefore, the observed calcium transients
in proximal tubular cells might originate from vascular ATP receptor populations.
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To this point, we could demonstrate that our method of ATP injection in vivo
is functional as we could induce calcium transients in endothelial cells of glomeruli
and in cells of the proximal tubulus but not in podocytes.
7.2.4 Differences between in vivo and ex vivo results
Data acquired from in vivo experiments applying laser-induced injury as a model
of podocyte injury clearly point towards a role of ATP in podocyte biology. Results
obtained using isolated glomeruli and podocyte cell culture data additionally
emphasize its relevance. In our ex vivo experiments we applied doses between 50
and 200 µM ATP to induce calcium transients. While, in the in vivo system we
injected between 0.5 and in most cases 2 µg of ATP. A dose of 2 µg ATP would
calculate to ∼ 3.6 µM when diluted in ∼ 1 ml of blood volume of a 3-4 week old
mouse (6-8 % of a mouse body weight). Since we injected ATP as a bolus in a
volume of 30 µl we injected ATP at a molarity of ∼ 120 µM. As 20 % of the heart
injection volume directly goes to the kidney we would expect that ∼ around 25 µM
ATP would directly arrive in the kidney. This dose is less than the minimal dose
of 50 µM we used on isolated glomeruli. And in contrast to the ex vivo situation,
blood and endothelial cells will consume ATP partially, therefore podocytes will
encounter only a fraction of ATP which was injected. We therefore hypothesize,
that we were unable to reach a sufficiently high concentration at the podocyte cell
membrane and therefore could not recapitulate results from our experiments with
isolated glomeruli. Since, ATP is a vasoactive compound and has a strong effect on
the mouse’s physiology we could not increase the dose to a sufficient degree without
severely affecting the blood pressure of the animal in the process. Furthermore, we
conclude that podocytes are less sensitive to ATP signaling compared to endothelial
cells and proximal tubular cells since we were able to induce strong calcium signals
while using less ATP. In order to achieve a higher concentration of ATP at the
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podocyte cell membrane we could use a different route of injection to deliver a
higher dose directly to the kidney. Furthermore, it would be of interest whether
podocytes show an increased sensitivity to ATP after an initial injury had occurred,
for instance after induction of Adriamycin nephropathy.
7.3 Concluding and perspectives
The focus of this thesis was to understand calcium signaling in podocytes using
2-photon intravital microscopy. Our approach puts experimental data obtained
from podocyte cell culture model and experiments with isolated glomeruli compared
to the in vivo situation into question. We focused on AngII- and ATP-mediated
calcium transients in podocytes.
Our results suggest that podocytes maintain low intracellular calcium levels
during a healthy state and dysregulation occurs during disease. High dose of AngII
elicted a calcium signal in only a minor fraction of glomeruli and podocytes in
healthy animals but significantly increased during disease. Our data might answer
why patients suffering from kidney disease presenting with proteinuria show the
biggest benefit from treatment with RAAS inhibitors beyond blood pressure control
[102]. Therefore, inhibition of RAAS might protect podocytes from direct effects
of AngII on calcium signaling in and thereby maintain its integrity. For ATP
stimulation we found that podocytes are less sensitive to ATP than endothelial and
proximal tubular cells. We therefore conclude, that a high local concentration at the
podocyte cell membrane is necessary to induce ATP-mediated calcium signaling.
In summary, the observed low responsiveness to AngII and ATP suggests that
maintenance of low intracellular calcium levels is crucial for podocytes.
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